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QUANTITATION OF TYPE I COLLAGEN mRNA IN INTACT HUMAN 
FIBROBLASTS 
EDWARD TOUMA 
ABSTRACT 
A number of human connective tissue disorders involve 
abnormalities in the synthesis of Type I collagen mRNAs. In 
order to screen large numbers of samples for such defects, a 
simple and rapid dot blot technique has been developed for the 
quantitation of collagen mRNA levels in small numbers of 
intact fibroblasts. Procedures devised for non-mammalian 
cells have been adapted for use with human fibroblasts. Cells 
growing in monolayer culture are harvested by trypsinization 
and fixed in phosphate buffered saline with 1% glutaraldehyde 
for 60 minutes at 4 °C. The cells are then washed and 
processed through a series of dehydration steps and finally 
resuspended in 70% ethanol. The desired number of cells is 
loaded onto a poly-L-lysine coated glass fiber filter under 40 
mm Hg of vacuum using a dot blot apparatus. After air drying 
the filter is incubated with proteinase K followed by 
triethanol amine and acetic anhydride treatments. The cells 
on the filter are then hybridized with RNA probes made from 
Type I collagen cDNAs or with nick translated probe for 28S 
ribosomal RNA. A strong signal is obtained with 5,000 cells 
per dot and the amount of hybridization to a dot can easily be 
quantitated by scintillation counting. The amount of cross 
hybridization between the probes utilized and structurally 
similar genes, and the specificity of hybridization of the 
probes to their target mRNAs was determined by southern blot 
analysis and the use of the sense-strand as a negative 
control, respectively. The sensitivity of the procedure can 
be increased by increasing the size of the probe used. 
However, the effect of hyperpolymer formation between the 
probe molecules and their target mRNA, limits such uses to 
detection purposes only. When quantitation of the absolute 
amounts of a particular mRNA species is desired, small probes 
must be used. 
The steady state levels of Type I collagen mRNA in two 
cell lines (GM0744 and GM02962) from individuals with the 
lethal form of osteogenesis imperfecta (OI) and one from a 
normal individual (GM03348B) were compared. The steady state 
level of total RNA, as measured by hybridization to the 28S 
rRNA probe, is elevated in both of the OI cell lines relative 
to the normal cell line. However, there was no proportional 
increase in the Type I collagen mRNAs. The levels of both 
collagen mRNAs are low in cell line GM0744 and only al{I) is 
low in cell line GM02962. The ratio of al(I) to a2(I) mRNA in 
GM0744 was the same as in GM03348B. However, the ratio of the 
two mRNAs was less than normal in GM02962. 
Depending on the size of the probe used, this method 
could be used for the quantitation of the absolute or the 
relative amounts of a particular mRNA in a large number of 
samples, facilitating the systematic screening of affected 
cell lines for further studies. 
QUANTITATION OF TYPE I COLLAGEN mRNA IN INTACT HUMAN 
FIBROBLASTS 
by 
Edward Touma 
Thesis Submitted to the Faculty of the Graduate School 
of Loyola University of Chicago in Partial Fulfillment 
of the Requirements for the Degree of 
Master of Science 
January 
1991 
(c) 1991, Edward Touma. All rights reserved. 
ACKOWLEDGEMENTS 
I would like to thank my committee members, Dr. Diane 
suter and Dr. John Smarrelli for their time and effort. I 
extend a very special thanks to my advisor, Dr. Jeffrey L. 
Doering for his assistance and guidance. I also would like to 
thank the people in the department of biology especially those 
in Dr. Doering's laboratory for their help on many occasions 
during the past years. Most of all, I thank my family for 
their constant love, support, and encouragment. Without their 
help my education would not have been possible. 
ii 
VITA 
The author, Edward Touma, is the son of Emmanuel Touma 
and Shoshan Touma. He was born on August 9, 1962, in Baghdad, 
Iraq. 
His high school education was completed in 1979 at Al-
Gymhoria High School, Baghdad, Iraq. 
immigrated to the United States. 
In October, 1980, he 
In June, 1987, he was awarded the degree of Bachelor of 
science with honor in Biology from the University of Illinois 
at Chicago. In September, 1987, the author was granted an 
assistantship in biology at Loyola University of Chicago, 
allowing him to complete the requirements for the degree.of 
Master of Science in 1991. 
In 1989, Edward Touma presented a poster at the American 
Society for Cell Biology/The American Society for Biochemistry 
and Molecular Biology joint meeting in San Francisco. He also 
presented posters at the Illinios State Academy of Science 
82nd Annual Meeting, 1989, and at the Graduate Research Forum 
sponsored by the Loyola University Chapter of Sigma Xi, where 
he was inducted into the society as an associate member. 
iii 
P.M. 
PUBLICATIONS 
Mathisen, E. Touma, A. Jurkowski, and L. Miller. 1987. 
The induction of keratin gene expresion during Xenopus 
development. !CSU short reports. Advances in Gene 
Technology: The Molecular Biology of Development. 7:89. 
E. Touma and J. Doering. 1988. A rapid method for determining 
Type I collagen mRNA levels in human fibroblasts. The 
Journal of Cell Biology. 107:804a. 
E. Touma and J. Doering. 1989. A rapid, improved method for 
determining Type I collagen mRNA levels in intact human 
fibroblasts. Transactions of the Illinois State Academy 
of science. 82:81. 
iv 
TABLE OF CONTENTS 
Page 
ACKNOWLEDGMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ii 
VITA . • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii 
PUBLICATIONS 
TABLE OF CONTENTS 
LIST OF FIGURES 
INTRODUCTION 
REVIEW OF RELATED LITERATURE 
MATERIALS AND METHODS 
RESULTS AND DISCUSSION 
CONCLUSION ............................................. 
REFERENCES 
v 
iv 
v 
vi 
1 
4 
33 
48 
102 
107 
LIST OF FIGURES 
Figure page 
1. The biosynthesis of procollagen Type I •...••••....• 27 
2. The translation and processing of 
procollagen Type I . . • • . . . . • • • • • • • . • . . • • • . . . • . . . 29 
3. Protein suicide ...•.....•••••••....••.•.••..•••••.• 31 
4. Subcloning ......................................... 44 
5. orientation of insert with respect to 
the SP6 promoter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 6 
6. Size analysis of RNAs synthesized 
from pGEM-4z plasmids •••••••••....•••.•.••..••• 73 
7. Effects of fixatives on cellular 
RNA hybridization .............................. 75 
8. Effects of RNA and nick translated 
probes on hybridization to cellular RNA .......• 77 
9. Effects of proteinase K treatment 
on hybridization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79 
10. Effects of hybridization volume on 
hybridization .................................. 81 
11. Cell number linearity and retention ••...•••••....•. 83 
12. Time dependence of in situ 
hybridization and cell retention ..•.••....•.... 85 
13. Effects of probe size on hybridization •....•••.•... 87 
14. Probe saturation . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . 89 
15. Effect of cell storage ••••••••..•••.••..•.......... 91 
16. Effect of dextran sulfate ...•••••••..••..••.••..... 92 
17. Effects of prehybridization ••..•......••....•...•.. 93 
18. Cross hybridization . . • • • • • • . . • • • • . • • • . • • . . . • . . • • . . . 94 
19. Hybridization specificity .•.•••..•................. 97 
20. Procedural flow chart ..•..••....•..••••.•..•••.••• 100 
vi 
LIST OF FIGURES (continued) 
Figure Page 
21. Quantitation of the relative amounts 
of Type I collagen and the ribosomal 
RNA in OI and normal human fibroblast ......... 101 
vii 
INTRODUCTION 
Osteogenesis imperfecta (OI) is a complex and heteroge-
nous human genetic disorder affecting the skeleton and other 
connective tissues. It is characterized by brittle bones and, 
to varying degrees, other abnormalities such as blue sclerae, 
presenile hearing loss, dentinogenesis imperfecta, joint 
hypermobility, and easily bruisable skin (Sillence et al., 
1979; Sillence et al., 1979b; Prockop and Kivirikko, 1984). 
Type I collagen is the major component in the tissues involved 
in or. It accounts for about half of the dry weight of the 
bone and over 80% of the dry weight of skin, tendons, and 
ligaments (Prockop and Kivirikko, 1984). Defects in the 
structure and/or synthesis of Type I collagen have been shown 
to be the main cause of the or phenotype (McKusick, 1972). 
Mutations in one or the other of the two genes coding for Type 
I collagen (COLlAl and COL1A2) are common in or, and include 
DNA rearrangements, missense mutations, and splicing muta-
tions. Many or cases are characterized by abnormal collagen 
amounts reflected both at the mRNA and protein levels (Bateman 
et al., 1988; Byers et al., 1988). 
Due to the diversity of the mutations that could cause 
or symptoms and the difficulty in identifying those cases with 
1 
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alterations in the levels of expression of Type I collagen 
genes, I opted to develop an in situ dot blot hybridization 
technique to screen for abnormalities in OI at the mRNA level. 
In situ dot blot method was chosen mainly for three reasons. 
The first is that this method requires no isolation and 
handling of RNA and thus is technically very simple to 
perform. Second, a large number of different samples can be 
analyzed at the same time, facilitating the rapid identifica-
tion of any abnormalities in the synthesis of the Type I 
collagen mRNA, which can then be studied further. Third, 
unlike other quantitation methods, this procedure requires a 
very small sample size (about 25,000 cells) to perform, thus 
making it very appealing in cases where sample size is limit-
ing. 
This study consists of two parts, the first being the 
development and optimization of a simple method to quantitate 
the steady state levels of Type I collagen mRNAs in intact 
human fibroblast cells. The method is a modification of in 
situ hybridization techniques developed for non-mammalian 
systems (Yu and Gorovsky, 1987; Lawrence and Singer, 1985; Cox 
et al., 1984). Poly-L-lysine-coated glass fiber filters are 
used instead of glass slides or other immobilizing media. 
Fibroblast cell cultures are used instead of whole tissue and 
thus a predetermined number of cells can be used. Long 32P-
labeled RNA probes are employed instead of nick translated DNA 
probes to increase the sensitivity of the assay. One draw-
3 
back to the use of large probes is the formation of a hyper-
polymer of the probe on the target mRNA. Consequently, the 
absolute quantity of mRNA can not be determined using large 
probes. The signal is detected by exposure to X-ray film and 
quanti tated by scintillation counting. The second part of the 
study tests whether the amounts of Type I collagen mRNAs in OI 
cell lines are different from that in normal fibroblasts by 
comparing the steady state levels of Ql(I) and Q2(I) collagen 
mRNAs in OI and normal fibroblasts. Using the 28S ribosomal 
RNA as a measure of the steady state of the total RNA, 
fibroblasts from OI patients appear to contain more RNA than 
fibroblasts from normal individuals. However, there is no 
proportional increase in the Type I collagen transcripts in 
these cells. Such screening may eventually characterize 
reproducible differences in collagen mRNA levels between the 
various classes of OI and quickly identify cases with collagen 
gene defects for further molecular genetic analysis. 
LITERATURE REVIEW 
structure and Processing of Type I Collagen 
Osteogenesis imperfecta, OI, is a highly heterogenous 
group of human diseases affecting bone and other connective 
tissues rich in Type I collagen (Sillence et al., 1979; 
Sillence et al., 1979b; Prockop, 1984). It is known that 
defects in Type I collagen are responsible for the majority of 
OI cases (for review see Byers et al., 1984; Cohn et al., 
1988; Bateman et al., 1988). Type I collagen is a hetero-
trimer made up of two al chains and one a2 chain 
((a1(I)] 2[a2(I)]). Each of the polypeptide chains is encoded 
by a single gene, COL1A1 and COL1A2 respectively. COL1A1 is 
located on chromosome 17 (Huerre et al. , 1982) and is 18 
kilobases (kb) in length (Chu et al., 1985). COL1A2 is 
located on chromosome 7 (Sykes and Solomon, 1978; Junien et 
al., 1982) and is 40 kb in length (de Wet et al., 1987). Both 
genes are made up of 51 exons interrupted by introns of widely 
divergent sizes (Figure 1). Each exon is composed of codons 
for the characteristic repetitive triplet, Glycine-X-Y, where 
X and Y may be any amino acid except tryptophan, tyrosine, or 
cysteine, and are often proline and hydroxyproline respective-
ly (for review see Prockop and Kivirikko, 1984; Byers et al., 
4 
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l984; Byers et al., 1987). Each exon begins with a glycine 
codon and ends with a Y codon and the majority of exons are 
multiples of nine nucleotides, the most common being 54 and 
108 base pairs (bp). Thus each exon corresponds to 6 to 12 
amino acid triplets (Wozney et al., 1981; Crombrugghe and 
Pastan, 1982). Based on these findings, it has been proposed 
that collagen genes evolved from an ancestral gene by multiple 
duplication or amplification of a single genetic unit contain-
ing a 54 bp exon (Yamada et al., 1980; Benveniste-Schrode et 
al., 1985). 
The collagen genes are transcribed into precursor mRNAs 
that contain copies of both the exons and intrans (Figure 1). 
The precursors are then processed by at least 50 splicing 
reactions to form the cytoplasmically translatable mRNAs. The 
transcripts from a single collagen gene are polymorphic in 
size due to the varying lengths of their 3 ' untranslated 
regions. In humans, two mRNAs of different sizes have been 
identified for pro-al(!) (Chu et al., 1982), and five for pro-
a2 (I) (de Wet et al . , 19 8 7) • 
After transcription and processing, the mRNAs are 
translated by ribosomes on the rough endoplasmic reticulum 
(RER) (Prockop et al., 1979; Hollister and Holbrook, 1984). 
The peptides are translocated across the RER membrane into the 
cisterna. Both a chains are synthesized as procollagen 
molecules consisting of a central triple helix flanked by an 
amino and a carboxyl propeptide. The NH2 and the COOH 
6 
terminals appear to aid in the "self assembly" process of the 
three chains into the characteristic triple helix. As the a 
chains pass through the membrane of the RER, certain prolyl 
and lysyl residues are hydroxylated (Figures 1 and 2), and 
some hydroxylysyl residues are glycosylated by enzymes within 
the cisterna (Kivirikko and Myllyla, 1982). After translation 
two al(I) and one a2(I) propeptides come together at the COCH 
terminal and start to wind around each other into a right 
handed triple helix (Prockop and Kivirikko, 1984; Byers et 
al., 1984). The twisting of the three chains proceeds in a 
zipper-like fashion from the carboxyl to the amino terminus. 
The hydroxylation and glycosylation reactions continue until 
the completion of the triple helix prevents any further 
modification to the procollagen chains. Therefore, the extent 
of hydroxylation and glycosylation are dependent upon the rate 
of triple helix formation (i.e., decreased rate of triple 
helix assembly causes an overmodif ication of the procollagen 
molecules). This fact will be important later in understand-
ing some of the mutations causing OI (Bateman et al., 1988). 
After the intracellular processing of procollagen, the 
molecules are secreted into the extracellular matrix where the 
amino and carboxyl propeptides are cleaved by specific 
extracellular proteinases. The mature collagen molecules are 
arranged and crosslinked into stable, quarter-staggered 
fibrils (Figure 1) • The crosslinking reaction occurs by 
catalyzing oxidative deamination of amino groups of specific 
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lysyl and hydroxylysyl residues between two adjacent collagen 
molecules (Prockop and Tuderman, 1982; Prockop and Kivirikko, 
l984). Lysyl oxidase is the extracellular enzyme involved in 
the deamination step. 
The two requirements which must be met for a stable 
collagen helix are a repeating Gly-X-Y sequence, and suffi-
cient praline, hydroxyproline, lysine, and hydroxylysine in 
the X and Y positions. The presence of glycine in every third 
position in the chain is conformationally essential for the 
formation of a helical molecule. The hydroxylation of 
praline is essential for stabilizing the procollagen triple 
helix under physiological conditions. Non-hydroxylated pro-a 
chains cannot form triple helical molecules at 37°C (Kivirikko 
and Myllyla, 1982). In addition to its role in molecular 
stability, the hydroxyl group of hydroxylysine serves as the 
site of attachment of carbohydrate units (glyocsylation) and 
the location of intermolecular collagen crosslinks (Bornstein 
and Traub, 1979). The later covalent bonds enable collagen 
fibrils to serve as the major structural elements in the 
connective tissues. These linkages stabilize the fibrils and 
confer on them the tensile strength necessary to withstand the 
tensions exerted in different parts of the body. 
Regulation of Type I Collagen Genes 
The collagen family consists of some twenty different 
genes that give rise to at least thirteen distinct collagen 
8 
molecules (Mayne and Burgeson, 1987). Various tissues 
synthesize a family of different collagen peptides, and thus 
mechanisms must exist for the regulation of the various types 
and amounts of collagens expressed in each cell type. The 
type(s) and amount(s) of collagen(s) are regulated at the 
transcriptional levels, but quantitative control may also be 
exerted at the translational and post-translational levels 
(i.e., through the regulation of the modification enzymes, 
rate of degradation of collagen, and concentration of certain 
substrates). 
The transcriptional regulation of the collagen genes is 
a complex process which involves both cis-acting and trans-
acting elements (Schmidt et al., 1986; Khillan et al., 1986). 
Like other eukaryotic genes, the collagen genes contain 
several regulatory sequences upstream and downstream of the 
transcription initiation site. A TATA box and a CAAT box are 
located within a few hundred base pairs of the transcription 
start site (Chu et al., 1985). These sequences are essential 
for the proper initiation of transcription (Lewin, 1987). In 
addition to regulation of transcription initiation the mouse 
a2(I) promoter region has been shown to contain sufficient 
information for the proper developmental and tissue-specific 
expression of a chimeric gene in transgenic mice (Khillan et 
al., 1986). Several other cis-acting regulatory sequences in 
the 5 1 region of collagen genes are also known to play a role 
in the expression of the collagen genes. For example, the 
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human al(I) gene contains two identical, GC rich, twelve bp 
direct repeats that increase the expression of a marker gene 
when studied in microinjected Xenopus laevis oocytes (Rossouw 
et al., 1987). These direct repeats have been shown to be 
highly conserved through evolution (Brenner et al., 1989). 
The mouse a2(I) collagen gene contains three upstream elements 
that serve as the binding sites for specific DNA-binding 
proteins. Mutations in these elements inhibit the binding of 
the trans-acting elements and decrease the activity of the 
mouse collagen promoter by eight to twelve fold (Karsenty et 
al., 1988). 
In addition to these upstream elements Type I collagen 
genes contain enhancer core sequences within the first intron 
(Rossouw et al., 1987; Rossi and Crombrugghe, 1987). Enhancer 
elements exert a positive regulatory effect on the transcrip-
tion of their respective genes in a distance- and orientation-
independent manner (Lewin, 1987). In the case of the al(I) 
gene, the enhancer, located between +700 and +1300, is flanked 
by a pair of inverted decanucleotide sequences on each side 
(Rossouw et al., 1987). These four consensus sequences serve 
as the sites for the binding of the RNA polymerase II consti-
tutive transcription factor, Spl (Kadonaga et al., 1986; 
Rossouw et al., 1987). It has been postulated that intricate 
regulatory control of the al(I) gene may be achieved by 
multiple interactions between a set of trans-acting factors 
that bind the promoter and 5' flanking sequence and a second 
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array of DNA-binding proteins that recognize intronic sequenc-
es (Bornstein and McKay, 1988). The mouse a2 (I) collagen gene 
contains two enhancer sequences between +418 and +1524 of the 
first intron (Rossi and Crombrugghe, 1987) • These enhancer 
elements are intermixed with several pentanucleotide inverted 
repeats. The a2 (I) enhancers exert a cell-specific transcrip-
tional activation of the gene (Rossi and Crombrugghe, 1987) . 
The quantity of collagen may also be regulated at stages 
beyond transcription. First, the amount of collagen produced 
is proportional to the amount of praline in the intracellular 
pool (Rojkind and Leon, 1970). A positive correlation between 
the concentration of free praline and the amount of collagen 
synthesized has been demonstrated in the liver fibrosis of 
rats and murine Schistosomiasis (Ehrinpreis et al., 1980; Dunn 
et al., 1977). The praline intracellular pool is affected by 
the catabolic activity of praline oxidase (the enzyme that 
converts praline into glutamate). Second, a highly conserved 
palindromic sequence around the translation initiation site 
(position +88 to position +135) of several collagen genes is 
capable of forming a hairpin structure which may regulate the 
translation (Chu et al., 1985). Third, the amino terminal 
peptide resulting from the cleavage of procollagen Type I and 
III molecules has been shown to exert a negative feedback 
effect specific for the synthesis of collagen (Wiestner et 
al., 1979; Paglia et al., 1979; Paglia et al., 1981). This 
biological activity resides in the NH2 terminal globular 
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domain of the propeptide, and can be demonstrated by adding 
this fragment or the intact amino propeptide to fibroblast 
cell cultures or to a reticulocyte lysate cell-free transla-
tion system of procollagen mRNA. These findings suggest that 
the NH
2 
terminal propeptide or a fragment of it may influence 
the efficiency with which the procollagen mRNA is translated. 
Although these peptides are present at a significant concen-
tration in various tissues and biological fluids (e.g., serum, 
Rohde et al., 1979), whether the regulatory mechanism exists 
in vivo is not yet known since the peptide's concentration in 
the extracellular matrix is much lower than that required to 
cause a reduction in the rate of collagen synthesis in 
cultured cells. Further, the mechanism by which the peptide 
exerts its effect is not known. 
Another level of control is post-translational. The 
amount of collagen secreted by cells is regulated through the 
degradation of a significant fraction of the newly synthesized 
procollagen within the cell (Bienkowski et al., 1978; Berg et 
al., 1980). This has been demonstrated by measuring the 
amount of low molecular weight hydroxyproline-containing 
peptides shortly after exposing the cells or tissue to 
radioactively labeled hydroxyproline. Approximately 30% of 
the newly synthesized collagen is degraded within the first 
1/2 hour of labeling (Bienkowski et al., 1978). The rate of 
the intracellular degradation is in turn regulated by other 
cellular factors such as levels of cAMP (Baum et al., 1980). 
12 
It is apparent from this discussion that the biosynthe-
sis of the collagen molecules is an intricate, multi-step 
process that requires precise biological control. Any error 
in this complex process may lead to deficiencies in the 
collagenous matrix, and in turn to some pathological condi-
tions. 
Qsteogenesis Imperfecta (OI) 
OI is a class of pathological conditions which are all 
characterized by bone fragility. The disorders result mainly 
from defects in the structural genes for Type I col lag en, 
although abnormalities in other components of the extracellu-
lar matrix (Dickson et al., 1975) or other collagen-like genes 
(Doering et al., 1987) may also be involved. The mutations in 
the collagen genes can be divided into two broad classes: 
structural and synthetic. The structural class includes point 
mutations and insertions or deletions of various sizes. 
Synthetic mutations include splicing defects and quantitative 
abnormalities in the expression of procollagen. 
OI has been classified into four different types based 
strictly on the clinical symptoms and the mode of inheritance 
(Sillence et al., 1979: Sillence et al., 1979b; Prockop, 
1984). The mildest form of OI is Type I. It is a dominantly 
inherited disorder and is characterized by osseous fragility 
that decreases at puberty, short stature, blue sclerae, 
deafness, and sometimes dentinogenesis imperfecta (Sillence et 
13 
al., 1979; Sillence et al., 1979b; Prockop, 1984). In a 
number of studies the phenotype has been shown, by analysis of 
restriction fragment length polymorphisms, to segregate 
consistently with one or the other of the two Type I collagen 
genes, COLlAl or COL1A2 (Tsipouras et al., 1984; Sykes et al., 
1986; Sykes et al., 1990). Thus, defects in the structural 
genes for Type I collagen are clearly responsible. Biochemi-
cally, most cases in this class are characterized by a 
quantitative reduction in Type I collagen protein of the skin 
and bones (Cheah, 1985; Byers et al., 1988; Bateman et al., 
1988; Barsh et al., 1982). Cultured skin fibroblasts from 
these patients synthesize about half the normal amounts of 
Type I collagen (Barsh et al., 1982; Rowe et al., 1985; Byers 
et al., 1988b). In some cases of this disorder the reduction 
in collagen propeptides is due to alteration in the absolute 
amounts of al(I) collagen mRNA (Rowe et al., 1985). In other 
cases the al(I) to a2(I) collagen mRNA ratio deviates from the 
normal 2:1 (Byers et al., 1988b; Bateman et al., 1988). This 
stoichiometric alteration in the levels of the two mRNAs 
ultimately results in a decrease in the amount of procollagen 
secreted by the fibroblasts. These results suggest that some 
regulatory mutation in the transcription of the collagen gene, 
altered stability of the collagen mRNA, and/or reduced 
transport of the mRNA from the nucleus to the cytoplasm may be 
the cause in these cases. In other cases, where no changes in 
mRNA levels are observed, translational defects and/or 
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increased post-translational degradation have been implicated 
(Byers et al., 1988b; Bateman et al. , 1988) . It is also 
possible in the latter cases, that although al(I) to a2(I) 
mRNA ratios are unaltered, there may in fact be a coordinate 
down regulation of both genes (Bateman et al., 1988) which 
would not be detected by the methods used in these studies. 
Although most cases of OI Type I are characterized by 
reduced levels of collagen, few cases with structural defects 
in collagen genes are known. A patient with OI type I studied 
by Sippola et al. (1984) and Kuivaniemi et al. (1988) was 
found to have a 19-bp deletion at the junction of the inter-
vening sequence 10 and exon 11 of the a2 (I) gene that produced 
an RNA splicing defect. The abnormal pro-a2 mRNA was spliced 
from exon 10 to 12. There was no quantitative alteration in 
either the collagen Type I protein or mRNAs. The patient 
produced equal amounts of normal and shortened pro-a2 (I) 
chains. The presence of a mutant pro-a2 chain in procollagen 
trimers caused a decreased thermal stability of the molecule 
and made it resistant to cleavage by the extracellular N-
protease. Another case studied by Steinmann et al. (1986), 
Cohn et al. (1988b), and Labhard et al. (1988) is the result 
of a point mutation in the al(I) collagen gene. The mutation 
results in the substitution of cysteine for glycine in the 
carboxyl terminus telopeptide of the mature molecule. The 
procollagen molecules had a normal denaturation temperature 
and normal translational modifications. Similar point 
15 
mutations in the triple helical region of al(I) result in a 
more severe form of OI, Type II (see OI Type II for explana-
tion). The reason for this is not known. 
OI Type II is the severest form of the disease. It is 
characterized by neonatal dwarfism, severe bone deformity, and 
usually results in death during or soon after birth. In most 
cases it is the result of new dominant mutations in the genes 
for Type I collagen (Bateman et al. , 1986; Byers et al., 
1988b), but in about 5% of the cases it is inherited in an 
autosomal recessive fashion (Byers et al., 1988b). At the 
biochemical level, OI Type II is also characterized by 
decreased collagen production. In the few cases where 
collagen mRNAs have been studied, altered levels have been 
found (de Wet et al., 1983a; de Wet et al., 1983b). In two 
patients the steady state ratios of pro-al(I) to pro-a2(I) 
mRNA were greater than 2:1 and the ratio of the two collagen 
proteins was increased proportionately (de Wet et al., 1983a). 
The presence of a non-functional a2(I) allele has been 
implicated in these altered mRNA ratios. However, most cases 
are caused by a point mutation in the triple helical coding 
region of Type I collagen genes. The point mutation is more 
frequently found in the al(I) gene than in the a2 (I) gene 
although a few such mutations have been found in the latter 
gene. The nature of the mutations is the replacement of 
glycine in the gly-X-Y repeat by another amino acid, commonly 
cysteine and arginine but also asparagine, valine, and serine 
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(Byers, 1989; Prockop et al., 1989). Since the presence of 
glycine, the smallest amino acid, in every third position is 
crucial for the formation of a functional triple helix, its 
substitution results in a decrease in the rate of the zipper-
like winding of the procollagen chains from the site of the 
mutation to the end of the chain, the amino terminal. The 
slower helix formation leads to a cascade of events: over-
modification of the polypeptide by co-translational and post-
translational enzymes, a decrease in the thermal stability of 
the trimers, increased intracellular degradation, and a 
decreased secretion of procollagen polypeptide (Bateman et 
al., 1988; Prockop et al., 1989; Steinmann et al., 1984; 
Williams and Prockop, 1983). 
In addition to point mutations, deletions and insertions 
in Type I collagen genes are known in OI Type II. In one 
patient a mutant al(I) gene had undergone intragenic recombi-
nation between two non-homologous introns, which resulted in 
a 651-bp deletion, removing three exons coding for 84 amino 
acids in the triple helical domain (Chu et al., 1985b; Barsh 
et al. , 1982) • The deletion caused an increase in the 
modification of the procollagen molecules containing a mutant 
chain and their decreased extracellular secretion (Barsh and 
Byers, 1981; Williams and Prockop, 1983; Penttinen et al., 
1975). As a result the ratio of Type I collagen to other 
extracellular matrix molecules was very low. Interestingly, 
the termini of the rearrangement were found to be located 
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within two short inverted repeats suggesting that the self-
complementary nature of these DNA elements may have favored 
the formation of a DNA secondary structure intermediate which 
served as a substrate for the "recombination deletion" 
reaction (Chu et al., 1985b). Another case of deletion has 
been found in the a2(I) gene. In this patient a heterozygous 
4.5 kb de novo deletion results in the removal of seven exons 
encoding 80 amino acids (residues 586-765) of the triple 
helical region (Willing et al., 1988). The intron-to-intron 
deletion preserved an integral number of the glycine-X-Y 
triplet repeats. The 5 1 junction of the deletion is located 
in the middle of a stretch of 23 AT base pairs but there is no 
evidence that this sequence is predisposed to recombination. 
In addition to deletion there is a case of insertion in one 
allele of the al(I) collagen gene. The insertion, toward the 
amino terminal of triple helical domain, is 70-80 amino acids 
long (Byers et al., 1988b). The insertion appears to result 
from the duplication of a multi-exon 600 bp segment of the 
al (I) gene. All of these cases of OI produce about equal 
amounts of mutant and normal Type I chains. The collagen 
molecules containing defective a chains become overmodified 
because of the delay in the triple helix formation of collagen 
molecules. These molecules are thermally unstable and are 
secreted either inefficiently or not at all. As a result, all 
of these cases are characterized by a reduced synthesis of 
collagen proteins. 
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OI Type III is a moderately severe form characterized by 
a progressive deformation of bones due to repeated multiple 
fractures. Both sporadic and autosomal recessive modes of 
inheritance have been demonstrated (Aitchison et al., 1988; 
sillence et al., 1979; Sillence et al., 1979b). In the 
majority of cases examined the defect does not appear to be 
associated with the collagen Type I genes. Many of the 
patients in this class of OI show no collagen Type I abnormal-
ities and the analysis of restriction fragment polymorphism 
markers indicated that the mutation is unlinked to either of 
the Type I collagen genes (Byers et al., 1987: Aitchison et 
al., 1988). Also, recent results in our lab indicate that in 
the majority of Type III OI patients, an Q2(I) complementary 
DNA (cDNA) probe detects deletions at one or the other of two 
discrete sites in a Type I collagen-like gene other than 
COLlAl or COL1A2 (Doering et al., 1987). While there is a 
significant reduction in Type I collagen production in some OI 
Type III fibroblast cells, this reduction does not correlate 
to altered Ql(I) to Q2(I) mRNA ratios (Bateman et al., 1988; 
Dickson et al., 1984; Bonaventure et al., 1986). Therefore, 
in most cases, mutations may be located not in Type I collagen 
genes themselves but in other genes which, by some unknown 
mechanism, produce OI with Type III phenotype. It has been 
suggested that some cases in this category may be due to 
abnormalities in the post-translational events (Bateman et 
al. , 1988) . 
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However, two Type III patients with structural mutations 
in rrype I collagen genes are known. In the first case, the 
patient acquired two defective alleles of pro-a2(I) from his 
phenotypically normal, third cousin parents (Dickson et al., 
1984; Pihlajaniemi et al., 1984). The recessive mutation had 
been stably inherited through at least five generations. The 
nature of the mutation is a four nucleotide deletion in the 
carboxyl propeptide (in exon number one) of the pro-a2 (I) 
gene. The deletion shifts the reading frame of the last 33 
amino acids of the propeptide and results in the utilization 
of a termination codon (TGA) four nucleotides 3' to the 
original termination site (TAA). Consequently, a2(I) collagen 
chains are not incorporated into the collagen molecule. 
Instead, thermally stable al(I) trimers are formed and 
secreted extracellularly. Fibroblasts from the parents 
secrete al (I) trimers in addition to normal Type I pro-
collagen. The second case involves a substitution mutation in 
the al(I) collagen gene (Pack et al., 1989). The glycine at 
position 844 is replaced by a serine. Although the phenotype 
in the proband was only moderate in severity, the nature of 
the mutation is very much like those found in lethal OI Type 
II. Why two similar mutations in the same general region 
result in two distinctly different phenotypes is not well 
understood. A possible explanation may lay in the fact that 
collagen chains are made up of thirteen "cooperative blocks" 
(Privalov, 1982). These blocks do not contribute equally to 
20 
the thermal stability of the protein (i.e., some blocks are 
more important than others to the over all stability of the 
molecule). Furthermore, glycyl residues in the same general 
region of the block are not equivalent in their stability 
factor. As a result, substitution of certain glycyl residues 
may have a more deleterious effect than the substitution of 
other glycyl residues within the same region. 
The least understood class, OI Type IV, is characterized 
by moderate clinical severity, limited degree of skeletal 
deformity, and blue sclerae which lighten with age. Inheri-
tance is usually dominant, although sporadic mutations are 
known to occur (Sillence et al., 1979; Sillence et al., 1979b; 
Prockop and Kivirikko, 1984). Biochemically, in addition to 
reduced collagen synthesis, most individuals with this form of 
OI produce two populations of Type I procollagen molecules, 
normal and overmodified (Bateman et al., 1988; Marini et al., 
1989; Wenstrup et al., 1986; Wenstrup et al., 1988}. The 
overmodif ied chains may be secreted extracellularly at a 
reduced rate. Unlike OI Type I, the reduction in collagen is 
not correlated with altered ratios of al(I) to a2(I} mRNA 
(Bateman et al., 1988). At the molecular level only a single 
case of OI Type IV has been found to be caused by a point 
mutation in the al(I) gene (Marini et al., 1989). The defect 
arose spontaneously in one of the al alleles and resulted in 
the substitution of serine for a glycine at amino acid residue 
832. The rest of the cases are due to defects in the a2(I} 
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qene. Two such cases have been examined in detail. The first 
involves an arginine substitution for the last glycine of the 
triple helical domain (position 1012) of the a2 (I) gene 
(Wenstrup et al. , 1988) • The second case involves a ten amino 
acid deletion from the middle of the a2 (I) triple helical 
domain (Wenstrup et al., 1986) • Because mutations in the 
a2(I) gene are less severe than similar mutations in the al(I) 
qene (see below) it has been postulated that point mutations 
in a2(I) chains are likely to be a common feature of the Type 
IV OI phenotype (Byers et al., 1988b; Falk et al., 1986). 
At first glance the innumerable mutations that give rise 
to the various clinical manifestations of OI render no 
consistent cause-and-effect relationship. Upon closer inspec-
ti on of the nature of the defects, however, some general 
features emerge. First, the evidence indicates that mutations 
resulting in decreased levels of collagen (transcriptional or 
translational abnormalities) are phenotypically less severe 
than mutations which affect the primary structure of the 
proteins produced (point mutations, deletions, and insertion) • 
The presence of a structurally abnormal pro-a chain in 
procollagen results in interference with the folding of the 
protein into the stable triple helical conformation, the 
processing of the NH2 terminal propeptide, or the assembly of 
processed collagen into normal fibrils (Prockop et al., 1989). 
Second, mutations in the pro-a2 (I) gene cause less severe 
symptoms than mutations in the pro-al(I) gene. stoichiometri-
22 
cally, the incorporation of a mutant pro-a2(I) chain results. 
in a 50% inactivation of the total procollagen trimers (Figure 
J; Williams and Prockop, 1983). The incorporation of a 
mutant pro-al(I) chain, on the other hand, causes the inacti-
vation of up to 7 5% of the procollagen molecules. These 
abnormal molecules are rapidly degraded either before or after 
secretion from the cell. This phenomena of destruction of 
collagen harboring abnormal a chains is called "protein 
suicide" (Figure 3). Third, large rearrangements in either of 
the genes of Type I collagen cause more severe symptoms than 
point mutations. Small deletions vary in the severity of 
their effects depending on the chain and the location of the 
mutation in the chain. Fourth, mutations located toward the 
amino end of procollagen cause milder OI phenotypes than 
similar mutations located at the carboxyl terminal. This is 
because the winding of the three a chains around each other 
proceeds from the COOH toward the NH2 terminal. As a result 
mutations closer to the carboxyl end cause a greater delay in 
the formation of the triple helix and consequently cause a 
greater degree of modification of the procollagen molecule. 
In situ Hybridization 
All forms of OI have reduction in collagen protein as a 
common biochemical feature, although the underlying defect may 
be very different from case to case. Mutations that give rise 
to structurally abnormal Type I collagen chains are more 
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accessible to analyses by current technologies than mutations 
that cause an alteration in the levels of expression of the 
qenes. Therefore, a simple method for quantitating the level 
of collagen gene expression in a large number of OI patients 
would be very helpful in further understanding the disorder. 
oue to recent advances in in situ hybridization techniques 
such quantitation at the mRNA level is possible. The in situ 
hybridization technique was first described by Gall and Pardue 
(1969). It allows the visualization of cellular DNA or RNA in 
tissue sections, single cells or chromosome preparations (Yu 
and Gorovsky, 1987; Brahic and Haase, 1978; Capco and Jeffery, 
1978). The technique has been used extensively in cell 
biology, gene mapping, prenatal and pathological diagnosis, 
and investigation of specific gene expression in tumor or 
normal cells. The technique has also been used successfully, 
but to a lesser extent, for quantitative purposes (Lawrence 
and Singer, 1985; Yu and Gorovsky, 1987). In situ hybridiza-
tion requires fixing of tissue or cells, immobilization, 
pretreatment, and hybridization of the sample with a radio-
labeled probe of interest. The results of hybridization are 
studied by either autoradiography or microscopy (light or 
electron). Several different fixatives have been used but 
glutaraldehyde (Yu and Gorovsky, 1987) and paraformaldehyde 
(Lawrence and Singer, 1985) are the most reliable since they 
provide for the most RNA retention. Glutaraldehyde is a 
stronger fixative than paraformaldehyde and as a result cells 
24 
treated with glutaraldehyde require extensive digestion with 
proteinase K to optimize hybridization. Different immobiliza-
tion media have also been utilized (e.g., cells embedded in 
paraffin or gelatin, cells fixed onto cover slip, or cells 
immobilized to poly-L-lysine coated glass fiber filters). For 
use with dissociated cells the latter immobilization method is 
the best for quantitation purposes because a predetermined 
number of cells can be loaded onto the filter (Yu and 
Gorovsky, 1987). The pretreatment and hybridization parame-
ters vary markedly among different researchers and from one 
cell type to another. 
Two in situ hybridization methods have been developed 
for the quantitation of mRNA. The first used paraformaldehyde 
to fix chicken embryonic muscle cells grown on coverslips 
treated with gelatin (Lawrence and Singer, 1985). The 
coverslips with the fixed cells were used directly in the 
hybridization reaction. The signal obtained was quantitated 
by scintillation counting of the coverslips. In this study 
paraformaldehyde was determined to be the fixative of choice 
because it provided for a good RNA retention, a good hybrid-
ization signal without a proteolytic treatment, the ability to 
use large probe fragments, and the advantage that cells 
treated with paraformaldehyde exhibit minimal autofluorescence 
(needed for use with fluorescent detection methods). The 
sensitivity reported was 20 copies of a 2 kb message per cell 
using nick-translated DNA probes. The second method was used 
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to quantitate histone mRNA in Tetrahymena thermophile (Yu and 
Gorovsky, 1987). It employed glutaraldehyde as a fixative and 
poly-L-lysine-coated glass fiber filters as the immobilizing 
medium. Complementary RNA probes with a mass average of 150 
bases were used for the hybridization. The signal was 
quantitated by densitometry or scintillation counting. Unlike 
paraformaldehyde-fixed cells, glutaraldehyde-fixed cells 
required proteolytic treatment to allow for optimum probe 
penetrability into the cell. The sensitivity limit was 1 or 
a few messages per cell. 
No quantitative in situ method has previously been 
devised for use with human cultured cells. Thus, such a 
technique had to be developed in the present study prior to 
examining collagen gene expression in fibroblasts of OI 
patients. 
The usefulness of in situ hybridization as a quantita-
tion method depends on the accuracy and sensitivity with which 
signals reflect the actual concentration of target mRNAs (Cox 
et al., 1984). Sensitivity has been increased by using high 
specific activity RNA probes corresponding to the coding 
strand and by decreasing non-specific binding of the probe to 
the immobilizing media by including ficoll, bovine serum 
albumin, and polyvinylpyrrolidone in the hybridization 
solution (Cox et al., 1984). The accuracy of in situ hybrid-
ization for RNA quantitation can be comparable to standard 
methods using purified RNA. The important advantage of in 
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_§).ty techniques is that no isolation or handling of unstable 
mRNA is required, and as a result a measure of true mRNA 
concentration per cell can be established. This method also 
allows for the relatively easy processing of more samples at 
one time. 
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Figure 1. The biosynthesis of procollagen Type I. Schematic 
representation of the al(I) and a2(I) genes. Gene structure: 
black box, exons; open box, introns. The two genes are 
transcribed and processed to yield the mature mRNAs which are 
translated on membrane-bound polysomes. The signal peptide 
cleavage, hydroxylation, glycosylation, disulfide bonding and 
helix formation occurs within the rough endoplasmic reticulum. 
The procollagen containing the amino and carboxyl propeptides 
are secreted into the extracellular matrix. Outside the cell 
the propeptides are cleaved by specific N- and c-proteinases. 
The mature collagen monomers are assembled into collagen 
fibrils by quarter staggered aggregation and cross-linking. 
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Figure 2. The translation and processing of procollagen Type 
I schematic representation of the events of collagen biosyn-
thesis that occur in the rough endoplasmic reticulum and their 
secretion. After translocation across the RER the hydroxyla-
tion of proline and lysine residues and the glycosylation of 
certain hydroxylysine residues are initiated. The formation 
of the triple helix stops the modification process. The 
protein is secreted through the smooth vacuoles of the cells 
into the extracellular matrix. Abbreviations: Gal, galactose; 
Glc, glucose; GlcNac, N-acetylglucosamine; (Man)n, mannose 
residues. 
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Figure 3. Protein suicide: Schematic representation of the 
effect of a mutant a(I) chain on the molecules containing it 
(pro-al8 ). The mutant chain becomes associated with normal 
pro-a chains into disulfide-linked trimers. The trimers 
containing mutant chains cannot fold into a stable triple 
helix at 37°C, and are rapidly degraded. In the presence of 
one mutant pro-al allele 75% of the molecules are affected. 
The presence of one mutant Pro-a2 allele, on the other hand, 
results in 50% defective molecules. 
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MATERIALS AND METHODS 
Bource and Preparation of RNA Probes 
The collagen cDNA clones encoding pro-al(I) (Hf404 and 
Hf677, Chu et al., 1982), pro-a2(I) (Hf32, Myers et al., 1981) 
and pro-a2 (V) (Ok25, Weil et al., 1987) were generously 
provided by Dr. F. Ramirez. The genomic clones for the 18S 
and the 28S ribosomal RNA (pXlr-11, Dawid and Wellauer, 1976) 
were a gift from Dr. I. B. Dawid. The cDNA clones for a 
tubulin and B actin (pTl and pAl, respectively, Cleveland et 
al., 1980) were provided by Dr. P. R. Musich. All of the 
above cDNAs were cloned in the plasmid vector pBR322. The 
genomic clones pXlr-12 and pXlr-11 were cloned in the Col El 
vector. The probes used in this study were prepared via 
either nick translation or in vitro transcription. Prior to 
nick translation the clones were cut by restriction enzymes to 
release the insert from the vector. The digested DNA was then 
used to make 32P labeled probe by the method of Rigby (1977). 
For the in vitro transcription the insert was first cloned 
into the pGEM-4Z vector (Promega Biotec, Inc.). This vector 
contains two promoters, SP6 and T7, flanking a polylinker into 
which the insert is cloned. The pGEM-4Z clones were linear-
ized by restriction digestion prior to use for in vitro 
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transcription (see below). 
Insert Isolation for Cloning 
Hf404 contains a 1.8 kb insert coding for residue 247 to 
residue 861 in the a chain of al(I). Hf677 contains a 1.475 
kb fragment coding for residue 787 to near the end of the 
coding region of al(I). The two al(I) cDNAs have 74 bps in 
common. Hf32 contains a 2.2 kb insert coding for residue 450 
of the a2(I) chain and extending to the middle of the COOH-
terminal propeptide. Ok25 encodes 3.6 kb of a2(V) collagen 
mRNA extending from the beginning of the a chain to the end of 
the carboxyl propeptide. pAl contains a 1. 9 kb insert 
encoding for nearly the full length of B actin. One hundred 
micrograms of each of the above plasmids were cut with the 
appropriate restriction enzyme(s) (EcoR I for Hf404, Hf677, 
Ok25; Pst I for pAl; EcoR I and Pst I for Hf32) to excise the 
insert from the vector. The Hf32 cDNA insert was cut into two 
fragments and the 3' portion (Eco RI/Pst I 1.1 kb fragment), 
corresponding to amino acid 871 of the a helix to amino acid 
1275 of c-propeptide, was used for the subcloning. In all 
other cases the full insert was used. The product of the 
digestion reaction was electrophoresed through 1% agarose, by 
standard procedures (Doering et al., 1982; Sims et al., 1983), 
to separate the plasmid from the insert DNA (Figure 4). The 
insert was isolated from the gel using the electroelution 
method of Dretzen (1981). 
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Ligation and Transformation -
The transcriptional vector pGEM-4Z (Riboprobe Gemini, 
promega Biotec, Inc.) used here contains the ampicillin 
resistance gene and lacz a-peptide gene. The later gene 
allows for blue/white color screening of recombinants 
{Yanisch-Perron et al., 1985). This plasmid was digested with 
the same restriction enzyme{s) used above for excision of the 
insert from the original vector. Different molar ratios of 
plasmid to insert were ligated (Figure 4) overnight at 4°C 
using 1 unit of T4 DNA ligase in T4 ligation buffer supplied 
by the manufacturer (BRL, Bethseda Research Laboratories). 
The ligation reaction was then used to transform ~ coli 
bacterial strain JM109 {Promega Biotec, Inc.) by the calcium 
chloride transformation method (Cohen et al., 1973). Trans-
formants were selected on ampicillin plates in the presence of 
4 mg/ml Bluo gal {BRL, in N,N-Dimethyl formamide) and 1 mg/ml 
isopropylthio-B-D-galactoside {IPTG, BRL). White colonies 
(containing recombinant plasmids) were isolated, a replicate 
prepared, and small-scale plasmid preparations were performed 
as described below. Restriction digests were then done to 
determine whether the desired insert was present and identify 
its orientation. Where possible, plasmids with the insert 
cloned in both orientations with respect to the SP6 promoter 
were isolated {see Figure 5). 
Ten mls of an overnight culture were centrifuged and the 
pellet was resuspended in 1 ml of lysis buffer (10 mM Tris-HCl 
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pH 7.5, 1 mM EDTA, 0.5% SDS). Twenty ug/ml of proteinase K 
were added to the solution, which was then mixed and incubated 
at 37 °c for 30 minutes. The salt concentration was brought up 
to 1.0 M by the addition of 370 ul of 4 M NaCl. The mixture 
was vortexed and incubated on ice for 1 hour. The chromosomal 
ONA and the cellular debris were pelleted in a 40 K rotor 
(Beckman) at 30,000 RPM for 30 minutes at o·c. The superna-
tant was extracted once with water-saturated phenol and once 
with ethyl ether. Samples were incubated at 65"C until the 
residual ether had evaporated. The plasmid DNA was precipi-
tated with 2 volumes of 95% ethanol at -20°c for at least 1 
hour. The DNA pellet was washed once in 70% ethanol, vacuum 
dried and dissolved in 50 ul of TE buffer (10 mM Tris-HCl pH 
8.0, 1 mM EDTA pH 7.9). Once the recombinant was identified, 
a large-scale plasmid preparation was carried out by a 
modification of the cesium chloride-ethidium bromide gradient 
method (Maniatis et al., 1982). 
In Vitro Transcription 
The templates for in vitro transcription were prepared 
by truncation of the plasmids downstream from the cloning site 
for the inserts. The message and anti-message RNA probes for 
all of the cDNAs, except a2(I), were prepared by transcription 
of plasmids containing the cDNA inserted in the two different 
orientations relative to the SP6 promoter (for example see 
Figure 5). Both T7 and SP6 promoters were used for the 
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synthesis of the sense or the anti-sense strand, respectively, 
of a2(I) RNA probes. The in vitro transcription was done 
according to the manufacturer's recommendations (Promega 
aiotec, Inc.). In some cases, after the in vitro transcrip-
tion the DNA template was degraded by incubation of the 
reaction mixture with 1 unit of RNAse-free DNase I (RQl DNase, 
Promega Biotec, Inc.) for 15 minutes at 37°C. The probe was 
then extracted with water-saturated phenol and purified away 
from the unincorporated nucleotides by running it through a 5 
ml Sephadex G-50-80 (Sigma Chemical co.) filtration column 
that was equilibrated and eluted with TE buffer. All solu-
tions used with the RNA probes were made with water that had 
been treated with diethyl pyrrocarbonate for 12 hours (DEPC, 
Sigma Chemical Co.) and then autoclaved. The amount of probe 
synthesized was calculated as follows: 
The total counts per minute (CPM) of the probe equals 
CPM X total volume of probe 
1 ul of sample 
Using the given specific activity (Ci/mmole) of the radioac-
tive nucleotide (CTP), the number of CTP nucleotides in the 
transcript, the average molecular weight of ribonucleotides 
(340 daltons}, and the number of decays per minute (dpm) per 
uci of radioactive nucleotide ( 2. 2x106 ) , the nanograms of 
transcripts present is calculated using the following formula: 
Total CPM X 1 uCi 
2. 2x106 dpm 
X 1 nmole 
specific activity of CTP 
X length of template X average MW of NTP 
number of CTPs in template 1 nmole 
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The number of counts per minute for 32p equals the number of 
disintegration per minute. 
radioactive nucleotide equals 
The specific activity of the 
daily specific activity of CTP 
ratio of radioactive to total amount of rCTP used 
RNA Gel Electrophoresis 
Radioactively labeled RNA samples were denatured by 
incubating O. 3 ng of each of the RNA probes in a 10 ul 
reaction containing 50% formamide, 2.2 M formaldehyde, and lX 
MOPS (10X: 0.2 M [3-(N-morpholino) pro-panesulfonic acid], 50 
mM sodium acetate, 10 mM EDTA adjusted to pH 7.0 and auto-
claved) at 65°C for 15 minutes and then chilling on ice. 
Prior to loading onto the gel, 2 ul of sterile loading buffer 
(50% glycerol, lmM EDTA and 0.4% bromophenol blue) was added. 
The RNA gel contained 1.0% agarose, 0.66 M formaldehyde and lX 
MOPS. All reagents were prepared in DEPC treated water. The 
gel electrophoresis apparatus was treated with 3% H2o2 for 15 
minutes prior to use to remove ribonuclease activity. 
Preparation of Poly-L-Lysine Coated Glass Fiber Filters 
The glass fiber filters (Whatman Glass Microfiber 
Filters 934-AH) were soaked in 50 ug/ml poly-L-lysine (150-
300,000; Sigma Chemical Co.) in 10 mM Tris, pH 8.0, at room 
temperature for 10 minutes, air dried in a folded piece of 
Blot Block paper (Schleicher and Schuell, Inc.) and stored 
with desiccant at room temperature for periods of up to a 
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month. 
cell Cultures and Fixation 
Control human fibroblasts (GM03348B) and fibroblasts 
from two patients with lethal variants of OI (GM0744, GM02962) 
were obtained from the National Institute of General Medical 
science Human Genetic Mutant Cell Repository. The cells were 
grown under standard conditions in Dulbecco' s Modified Eagle's 
media (Gibco) containing 10% fetal bovine serum (Gibco), and 
50 units/ml of each penicillin and streptomycin (Gibco). The 
fibroblasts were passaged with 0.06% trypsin (Gibco) in 
phosphate-buffered saline (PBS, 8 g/l NaCl, 0.2 g/l KCl, 1.15 
g/l Na2HP04 , 0.2 g/l KH2Po4 , pH 7.0-7.2). Cell cultures 
between passage 6 and 13 were used exclusively in this study. 
At confluency, the cells were harvested by trypsinization and 
washed twice with PBS (de Wet et al., 1983a). The pellet from 
a 25 cm2 plastic flask (Falcon) was resuspended, by pipetting, 
in 1 ml PBS containing either 1% glutaraldehyde (Sigma 
Chemical Co., Grade I, 25% aqueous solution) or 4% paraformal-
dehyde (Fisher Scientific, reagent grade). Fibroblast cells 
suspended in glutaraldehyde were mixed for 30 seconds at room 
temperature and placed on ice for 1 hour with occasional 
mixing by pipetting. Fibroblast cells suspended in paraforma-
ldehyde were mixed and incubated at room temperature for five 
minutes. The cells were then pelleted for 2 minutes in a 
clinical centrifuge and sequentially dehydrated by washing 
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twice for 10 minutes in ice-cold water, twice for 15 minutes 
in 50% ethanol on ice, and once for 25 minutes in 70% ethanol 
on ice. Cells were finally resuspended in 70% ethanol (1 
ml/25 cm2 flask), counted and stored at -2o·c (glutaraldehyde) 
or 4"C (paraformaldehyde). 
3H-labeling of Fibroblast Cells 
Human fibroblast cells near confluency were incubated 
with 5 mls of media containing 25 uci of 3H-thymidine. The 
stock solution of the 3H-thymidine was 1 uCi/20 ul of medium. 
The cells were incubated in this medium for 1 day. The 
radioactive medium was decanted and the cells washed several 
times with PBS. The cells were then fixed with 1% glutaralde-
hyde as described above. 
Loading and Treatment of Cells 
Filters were placed in a 96 well micro-sample filtration 
manifold (Schleicher & Schuell, Inc.) and moistened with 10 mM 
Tris, pH 8.0. The manifold was connected to an aspirator or 
a vacuum pump and the desired number of cells, in 100 ul of 
70% ethanol, was loaded onto the filters under a vacuum of 
about 40 mm Hg (weak). The filter was then removed and air 
dried on a piece of Blot Block paper for about 45 minutes. 
Filters were then incubated with 10 ug/ml (unless stated 
otherwise) of proteinase K (BRL) in proteinase K buffer (lOOmM 
Tris-HCl pH 8.0, 50mM EDTA in non DEPC-treated water) at 37°C 
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for 40 minutes (unless stated otherwise) in a Zip Lock bag. 
After the proteinase K treatment the filters were rinsed 
briefly in proteinase K buffer, immersed in 0.1 M trietha-
nolamine (J. T. Baker Chemical Co., Trolamine) pH 8.0 at room 
temperature for 10 min, and then in 0.1 M trolamine plus 0.25% 
acetic anhydride (Baxter Scientific Products, added immediate-
ly before use) at room temperature for 10 min. The filters 
were finally rinsed in proteinase K buffer and allowed to air 
dry on a piece of Blot Block paper. The rinsing and trolamine 
treatments were done in a small plastic tray with sufficient 
volume to cover the filters. 
Hybridization Conditions and Southern Blotting 
Due to the sequence similarity among the different 
collagen and structurally similar genes, conditions had to be 
determined that prevent cross hybridization. This was done 
using Southern blotting. Several collagen and structural 
cDNAs were digested with the appropriate enzyme to excise the 
inserts. The products of the restriction digests were 
electrophoresed on 1% agarose gels by established methods 
(Sims et al., 1983). The DNA was transferred to Gene Screen 
Plus membranes (NEN Research Products) using the alkaline 
method (Reed and Mann, 1985). The membranes were incubated 
overnight at 45"C with 35 ng of RNA probe per ml of hybridiza-
tion solution. A prehybridization step was not included in 
this procedure (see Results and Discussion). The hybridiza-
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tion solution contained 50% formamide (Fluka), 10% dextran 
sulfate (Pharmacia), 0.05 M Tris-HCl pH 8.0, 10 mM EDTA, 1% 
sos, lX Denhardt's solution [SOX: 1% Bovine Serum Albumin 
(Sigma), 1% Ficoll (Pharmacia), 1% Polyvinyl pyrrolidone 
(Sigma)] and 0.2 M NaCl. After hybridization, the membranes 
were washed in three changes of 2X SSC (lX; 0.15 M NaCl, 0.015 
M sodium citrate, 1 mM EDTA, pH 7.9) for 5 min each at room 
temperature, two changes of o.osx SSC for 20 min each at 65°C, 
and finally with o.osx SSC for 5 min at room temperature. The 
membranes were then air dried slightly and exposed to Kodak X 
ray film with or without Cronex intensifying screens (Doering 
et al., 1982). 
Hybridization to Intact Human Fibroblasts 
The hybridization solution used in the in situ hybrid-
ization with the cells is identical to that used in the 
southern blots except for the elimination of 1% sos. The 
filters were placed in Zip Lock bags, the probe was mixed with 
the hybridization solution at 40 ng/ml, unless stated other-
wise, and 0.2 ml/cm2 of the solution was added to the filters. 
Hybridization was at 45°C for 16-20 hrs. The washes were the 
same as those used in the Southern blotting above. The 
filters were air-dried and autoradiographed. The amount of 
hybridization was quantitated by punching out of the dots and 
counting them in a scintillation counter. The hybridization 
to the cells was adjusted by subtracting the background 
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hybridization to the filter. 
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Figure 4. Subcloning: Both the plasmid containing the insert 
(Hf677) and the vector into which the insert is to be placed 
(pGEM-4Z) are digested with the same enzyme (i.e., an enzyme 
that would excise the insert, Eco RI). After the isolation of 
the insert by electroelution from the agarose gel, it is 
ligated into the new vector as described in Materials and 
Methods. 
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Figure 5. Orientation of insert with respect to the SP6 
promoter. After the ligation of the insert into the vector 
and the transformation into JM109 ~ coli bacteria, two 
plasmids with the insert placed in opposite orientation with 
respect to the SP6 promoter are isolated. The templates for 
the in vitro transcription reactions are prepared by the 
linearization of the plasmids downstream from the insert. 
sense or anti-sense transcripts are generated using the SP6 
RNA polymerase depending on the orientation of the insert. 
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RESULTS AND DISCUSSION 
SYNTHESIS OF RNA PROBES 
The probes used in this study were cloned in the pGEM4z 
vector so that both sense and anti-sense RNA transcripts could 
be generated. The quantity of RNA synthesized was controlled 
by altering the amount of cold CTP nucleotide used in the 
transcription reaction. Also, by changing the concentration 
of the cold nucleotide the specific activity of the probe 
produced was altered. Thus, increasing the amount of the cold 
CTP yielded larger quantities of RNA transcripts with a lower 
specific activity. A typical in vitro transcription reaction 
contains 0.4 ug of template DNA, 3.5 uM radioactive CTP, 12 uM 
cold CTP and 10-15 units of RNA polymerase. The RNA yield 
from such a reaction is about 200 ng. In cases where large 
quantities of probe are desired, the concentration of the cold 
nucleotide is increased to 25 uM and the yield obtained is 
approximately twice as much. Both RNA polymerases, SP6 and 
T7, produce about the same amount of RNA in comparable 
reactions. 
RNA molecules are very susceptible to degradation by the 
activity of ubiquitous ribonucleases. Probes synthesized by 
in vitro transcription may even be more sensitive, presumably 
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because they lack the 5' cap and the 3' polyadenylation 
sequences (Sambrook et al., 1989). Therefore, it was impor-
tant to demonstrate that the synthesized RNA was intact and of 
correct size. As Figure 6 shows, all of the RNA transcripts 
used in this study are of the expected size and no degradation 
is detected. However, two abnormalities can be seen in this 
autoradiograph. First, the product of transcription of B 
actin cDNA (lane 5) shows a major band (A) smaller than the 
expected size. The synthesis of less-than-full length 
transcripts can be due to (i) the fortuitous occurrence in the 
template of sequences that terminate transcription by the DNA-
dependent SP6 RNA polymerase used and/or (ii) limiting 
concentrations of precursor (the radio labeled nucleotide; 
Sambrook et al., 1989). The latter condition is unlikely 
because the band is of a discrete size instead of the smear 
that would be expected if 32P-CTP was limiting. Premature 
terminations are probably caused by the formation of a stable 
secondary structure preventing the RNA polymerase from 
proceeding to the end of the DNA template (Lewin, 1987, 
chapter 11). Second, the transcription of the a2(I) collagen 
sense strand (lane 7) , which is the only RNA transcript 
generated using the T7 RNA polymerase, shows a minor band (B} 
that is larger (approximately 2.4 kb) than the insert. This 
band is equal in size to the vector sequence, pGEM4z, indicat-
ing that occasionally the T7 RNA polymerase recognizes and 
binds to the T7 promoter but for some unknown reason it 
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proceeds in the opposite direction transcribing the wrong 
strand of the vector sequence instead of the insert (Melton et 
al., 1984). In the other samples (lanes 1-6} where SP6 RNA 
polymerase is employed no such extraneous transcripts are 
seen. Results from work done on in vitro transcription using 
T7 RNA polymerase show that this enzyme has a higher tendency 
to initiate transcription at non-specific sites than SP6 RNA 
polymerase (data not presented; BMBiochemica, 1988} and 
therefore SP6 RNA polymerase was preferably used whenever 
possible. These results demonstrate that these RNA probes are 
basically being synthesized correctly and can thus be used in 
the present study. 
HYBRIDIZATION TO INTACT HUMAN FIBROBLASTS 
Fixatives 
In the present study, hybridization to RNA in intact 
cells requires a fixative which provides for the highest RNA 
retention in the cells and the maximum hybridization signal. 
These criteria are dependent upon the fixative's ability to 
inactivate all endogenous ribonucleases that may be present, 
provide for the maximum diffusion of probe throughout the 
cytoplasmic matrix, and preserve the cellular RNA. Two of the 
most frequently used fixatives, glutaraldehyde and paraformal-
dehyde, were evaluated to determine which would be more 
suitable for this work. Normal human fibroblasts (GM03348B) 
were harvested by trypsinization and split into two halves. 
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one half was fixed with 1% glutaraldehyde and the other half 
with 4% paraformaldehyde as described in Materials and 
Methods. Triplicates of each sample with 5000 cells per dot 
were loaded onto poly-L-lysine coated glass fiber filters. 
The filters were then digested with 10 ug/ml of proteinase K 
at 37 °C for various periods of time followed by triethanol 
amine and acetic anhydride treatments (see Materials and 
Methods). The filters were then hybridized to the al(I) RNA 
probe. The hybridization intensity to glutaraldehyde-fixed 
cells increased with increasing time of proteinase K treatment 
until it reached a plateau at 20 minutes of digestion (Figure 
7; see proteinase K concentration and digestion time section). 
Paraformaldehyde-fixed cells on the other hand, reached a 
maximum signal after a very brief treatment with proteinase K 
(2.5 minutes) and the signal intensity declined gradually with 
increased treatment. The maximum signal obtained with 
glutaraldehyde-fixed cells is two-fold higher in intensity 
than that obtained with paraformaldehyde-fixed cells. Two 
conclusions can be drawn from this experiment. First, 
glutaraldehyde is apparently a much stronger fixative than 
paraf ormaldehyde and thus provides for a tighter crosslinking 
of the cellular matrix. Consequently, a longer proteinase K 
digestion is required for optimum probe accessibility to RNA 
in glutaraldehyde-fixed cells. Second, the weaker signal with 
paraformaldehyde-fixed cells may indicate that this fixative 
does not provide for maximum RNA retention in the cell, 
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resulting in the loss of the cellular RNA with extended 
proteinase K treatment. It is also possible that paraformal-
dehyde does not completely inactivate the endogenous ribo-
nucleases, thus resulting in degradation of some cellular RNA. 
In any case, the stronger signal obtained with glutaraldehyde 
makes it the preferred fixative for the present study. 
A study done by Lawrence and Singer (1985) comparing the 
fixation of chicken embryo muscle cells with 4% paraformal-
dehyde and 4% glutaraldehyde yielded results similar to those 
presented here. They showed that glutaraldehyde provides for 
a better RNA retention than paraformaldhyde, and upon extended 
proteinase K treatment, the hybridization signal increased in 
glutaraldehyde-f ixed cells while paraformaldhyde-f ixed cells 
lost more than half of the total cellular RNA. In an apparent 
contradiction, however, they concluded that paraformaldhyde 
yields a superior signal-to-noise ratio compared to glutaral-
dehyde. This was probably due to the fact that their cells 
were fixed with a higher glutaraldehyde concentration (4% vs 
1% used in this study) and so, relative to my results, their 
proteinase K treatment time was grossly inadequate for maximum 
hybridization. As a result paraformaldehyde-fixed cells 
appeared to yield a more intense signal. 
RNA vs. Nick Translated Probes 
Several studies have shown that RNA probes are pref erred 
over nick-translated probes for in situ hybridization ·because 
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they provide for a higher degree of sensitivity (Yu and 
Gorovsky, 1987; Cox et al., 1984; Deleon et al., 1983). RNA 
and nick-translated probes were compared to determine their 
hybridization intensity with glutaraldehyde and paraformal-
dehyde fixed cells. Comparison of autoradiographs in Figure 
s clearly shows that the signal intensity obtained from the 
use of RNA probe (A) is vastly higher (about 100-fold) than 
that obtained from nick-translated probe (B). Consequently, 
RNA probes were employed in this study. Glutaraldehyde 
fixation followed by proteinase K treatment gave the strongest 
signal with either type of probe. 
Proteinase K Concentration and Digestion Time 
Almost every in situ hybridization procedure includes a 
step of post-fixation treatment of cells with proteinase in 
order to improve the hybridization (Brahic and Haase, 1978; 
Angerer and Angerer, 19 81 ; Edwards and Wood, 19 8 3 ) • The 
rationale for this is that the partial digestion and removal 
of some of the cytoskeletal and cytoplasmic proteins allows 
for a greater penetration of the probe through the cellular 
matrix and thus provides for a greater accessibility of mRNA 
for hybridization. The optimum treatment for human cells in 
the current study was determined using two approaches. The 
first approach involved the incubation of human fibroblast 
cells, spotted onto the poly-L-lysine-coated glass filters, 
with increasing concentrations of proteinase K for a fixed 
amount of time. 
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After the hybridization the signal was 
quantitated and the results plotted as the percent of maximum 
counts. As shown in Figure 9A the hybridization signal 
reached a maximum at about 10 ug/ml of proteinase K. Increas-
ing the amount of proteinase K above 15 ug/ml resulted in a 
gradual decrease of the signal, indicating that the cellular 
RNA was probably being lost in a similar fashion to that in 
the proteinase K treatment of cells fixed with paraformal-
dehyde. In the second approach, the amount of proteinase K 
was held constant (10 ug/ml) and the incubation time was 
varied (0 to 70 minutes) to determine the effect of digestion 
time on signal intensity. The hybridization signal increased 
dramatically in the first 15 minutes and then leveled off at 
about 25 minutes (Figure 9B). Further increase in incubation 
time did not appear to make a significant difference in the 
hybridization intensity over the length of time tested. 
Consequently, an incubation period of 40 minutes with 10 ug/ml 
of proteinase K was chosen as a standard for all experiments. 
OPTIMIZING HYBRIDIZATION PARAMETERS 
There has been little in situ hybridization work done on 
cultured cells (Yu and Gorovsky, 1987; Scharffetter et al., 
1989; Scharffetter et al., 1989b) and none on hybridization to 
dissociated human fibroblast cells. Therefore, in order to 
maximize the hybridization to fibroblasts, a number of 
parameters, such as cell number, hybridization volume, 
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hybridization time, probe size and concentration had to be 
optimized. 
Hybridization Volume 
The volume of the hybridization solution should be kept 
low since the kinetics of nucleic acid reassociation are 
faster in higher concentrations (Sambrook et al., 1989). 
Moreover, in small volumes the actual amount of probe used for 
the hybridization is reduced, minimizing the use of radioac-
tive materials. However, it is essential that sufficient 
solution be present at all times so that the filters remain 
covered with a film of hybridization solvent. Therefore, the 
minimum volume of hybridization solution required for maximum 
signal intensity was investigated. The bar graph in Figure 10 
shows that the hybridization signal increased significantly in 
the first two conditions (0.08 and 0.10 ml/cm2) followed by 
only a slight increase at the remaining two volumes (0.20 and 
0.30 ml/cm2). The volume of 0.2 ml/cm2 was chosen for the rest 
of the experiments because it was the smallest volume yielding 
a maximum signal. 
Linearity of Signal and Cell Number 
The linearity of hybridization signal with increasing 
number of cells was investigated to determine the maximum 
number of cells that could be loaded onto the glass fiber 
filters. Five to thirty thousand cells per dot were spotted 
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and the filters were treated and hybridized as previously 
described. The signal intensity increased linearly with 
increasing number of cells up to twenty thousands cells 
(Figure llA). Beyond twenty thousand cells the increase in 
hybridization was non-linear. Another more detailed study of 
linearity over the lower range of cell numbers (1-14 thousand 
cells} was also done (Figure llB). The hybridization signal 
obtained was completely linear over this range of cell 
numbers. 
Another experiment was done to determine whether the 
non-linearity of the signal beyond twenty thousand cells is 
due to (i) the limited amount of probe available for hybrid-
ization or (ii) the fact that the capacity of the filter to 
retain more cells was exceeded. Fibroblast cells that were 
labeled with 3H-thymidine served as a marker for the presence 
of fibroblasts on the glass fiber filters. An experiment 
similar to that in Figure llA was done using these cells, 
except that the probe was not included in the hybridization 
because the strong signal from the 32P-label would mask the 
weaker 3H signal. As shown in Figure llC the curve from this 
experiment clearly indicates that the capacity of the filter 
to retain cells is not exceeded. Therefore, the leveling off 
seen in Figure llA is due to a limiting amount of probe 
present in the hybridization solution when large number of 
cells are used. The maximum number of cells actually required 
for this protocol is well below the 20 thousand maximum. Most 
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experiments in this study used cell numbers in the range of 
sooo cells per dot. 
It is important to point out that the number of cells 
retained on the filter may vary from one cell type to another. 
Additionally, the condition of the cells before harvesting may 
also affect that number. Work done by Yu and Gorovsky ( 1987) , 
using a procedure similar to that in the present study, 
established that the maximum number of Tetrahymena 
thermophilia cells that could be loaded onto the filter was 
ten thousand. This number increased to three times as much 
when starved Tetrahymena thermophilia cells were used. 
Hybridization Time 
The length of hybridization time used in other types of 
in situ techniques is another parameter that varies greatly 
among different studies and could range from 3 to 72 hours 
(Scharffetter et al., 1989; McCabe and Pfaff, 1989; Yu and 
Gorovsky, 1987). To test the optimum hybridization time, 
triplicate fibroblast samples were loaded onto the glass fiber 
filters and hybridized to the al(I) RNA probe for different 
lengths of time (Figure 12A) • The hybridization signal 
intensity plotted against time shows that an incubation period 
of 16 to 24 hours is required for maximum hybridization 
signal. The signal intensity gradually declined after 24 
hours of hybridization. To determine whether this decline was 
due to the loss of cells from the filter or the loss of RNA 
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from the cells, 3H-labeled cells were used again. Tritiated 
cells were loaded, treated and hybridized as in the experiment 
above except that the probe was excluded from the hybridiza-
tion solution. The results (Figure 12B) demonstrate that the 
number of cells on the filters remains unchanged with time 
(i.e., the counts were essentially constant across all of the 
data points). Thus, cells are not being lost with extended 
periods of hybridization. Rather, it is likely that the 
cellular RNA is either being degraded or leaking out of the 
cells at longer hybridization times. Hybridization times of 
16-20 hours were used for all of the experiments. 
Probe Size 
Investigators disagree as to whether smaller or larger 
probes are more useful for in situ hybridization. Some 
researchers suggest that the use of larger probe enhances the 
signal due to the high specific activity of the molecule 
(Gerhard et al., 1981; Lawrence and Singer, 1985). Others 
maintain that smaller probe fragments, below 300 base pairs, 
are essential for successful accessibility of the probe into 
the cells or tissue (Brahic and Haase, 1978; Angerer and 
Angerer, 1981). Furthermore, larger probes may be problematic 
because of difficulties in washing them out of the cells. The 
effect of probe size on hybridization signal intensity was 
determined using al(I) probes of different sizes (1.5 and 0.7 
kb). The collagen template was truncated at different 
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distances from the SP6 promoter and labeled RNA probes of 1.5 
kb (4z6671/Xba I) or 0.7 kb (4z6671/Xho I) were synthesized. 
The GC contents of the two probes did not vary greatly (30% vs 
32% respectively) and therefore the specific activity per unit 
length of the two probes differs only slightly. However, the 
specific activity per transcript differs by about two fold due 
to the difference in size. These probes were hybridized to 
cells spotted onto two identical sets of filters (Figure 13A). 
one set was washed at 65°C and the other at a lower stringen-
cy, 55°C. Filters in each set were hybridized to either equal 
amounts or equal numbers of transcripts of the two probes 
(Figure 13A). 
The results summarized in Figure 13B clearly show that 
there is a large difference in the hybridization intensity 
between the two probe sizes. The 1.5 kb probe gives 8 to 9 
(or 13 when equal number of transcripts are compared) fold 
higher hybridization signal than the o. 7 kb probe. The 
differences in signal with the two probe sizes are much 
greater than can be accounted for by their two-fold difference 
in specific activity per transcript. There is no significant 
variation in the hybridization intensity between the two 
washing stringencies (i.e., the ratio of the larger probe to 
the smaller probe is virtually the same in both washing 
conditions). Thus, differences in the stability with which 
the two probes hybridize to cellular mRNA cannot account for 
the large signal differences. All experiments for testing the 
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various parameters and conditions of hybridization were done 
using al{I) probe of size 1.5 kb. The quantitation experi-
ments utilized the largest possible probe for each gene (see 
Materials and Methods for sizes). 
Probe Saturation 
To measure the absolute number of a particular species 
of mRNA molecule in a cell, it is necessary to hybridize to 
saturation by using excess amounts of probe. The quantity of 
probe required for hybridization to saturation was determined 
by incubating cell-containing filters with increasing amounts 
of probe. Figure 14 presents the concentration curve obtained 
for normal human fibroblasts hybridized to the al(I) collagen 
probe. The hybridization signal increased sharply with 
increasing probe concentration up to approximately 2 ug/ml of 
probe. A plateau was reached at about 3 ug/ml. The back-
ground increased somewhat with higher probe concentrations. 
This saturation concentration is comparable to that seen in 
other in situ hybridization studies (Yu and Gorovsky, 1987; 
Lawrence and Singer, 1985; Cox et al., 1984). 
The average number of collagen Type I mRNA molecules 
hybridized per cell can be calculated from the counts per 
minute of probe hybridized per dot at saturation (42000 CPM), 
the number of cells per dot (5000 cells), the total amount of 
probe used in the experiment (5394 ng) and the total counts 
per minute of the probe (9.0X108 CPM). The calculation was 
done as follows: 
A molecule of al (I) RNA transcript weighs 8. 4X10·10 ng. 
1.5X103 nucleotide/molecule of alCI} X 340 gm 
6X10n molecules/mole mole 
The amount of probe bound per sample equals 
42000 CPM/sample X 5394 ng total probe 
9.ox108 total CPM 
= 2. 5X10" 1 ng/sample 
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This quantity of probe corresponds to 3Xl08 molecules per 
sample as calculated below, 
2. sx10·1 ng/sample 
8. 4Xlo· 10 ng/molecule of al (I) mRNA 
which in turn equals 
3Xl08 molecules/sample = 6Xl04 molecules of al(I) per cell 
sx103 cell/sample 
These calculations indicate that there are sixty 
thousand copies of the al (I) collagen mRNA per fibroblast 
cell. This number is much higher than expected. According to 
Hastie and Bishop (1976), the number of the most abundant 
messages present in any cell type is around 10-12 thousand 
copies per cell. The number we obtained from our calculation 
is five times higher, suggesting that multiple molecules of 
al(I) RNA probe bind to every target collagen mRNA in the cell 
{see conclusion). 
Cell Storage 
RNA molecules are very susceptible to degradation by 
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ribonucleases which can be introduced from various sources. 
To determine the rate of degradation and/or loss of cellular 
RNA in stored cells, batches of normal human fibroblast cells 
were harvested and fixed on different dates and stored at -
20°c until hybridization. Triplicates from each sample were 
loaded onto the glass fiber filter and then treated and 
hybridized as described in Materials and Methods. As Figure 
15 shows, the signal obtained decreased gradually with storage 
time over the period tested. The signal decreased by about 
66% at the end of four months. However, there did not seem to 
be any significant decrease in the amount of signal for at 
least two months. Cells that had been stored for less than 
one month were used in all experiments. Similar experiments 
performed on fibroblast cells fixed with 4% paraformaldehyde 
showed a much more rapid loss of signal with storage time 
(data not shown) • Thus, RNA in such cells is more susceptible 
to degradation and/or loss than it is in glutaraldehyde-f ixed 
cells, further indicating that glutaraldehyde is a much 
stronger and better fixative than paraformaldehyde. 
HYBRIDIZATION CONDITIONS 
To obtain the maximum signal-to-noise ratio and the 
least amount of cross hybridization among different collagen 
types a number of hybridization parameters had to be studied 
and optimized. 
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.a.extran Sulfate 
A number of studies have shown that in the presence of 
10% dextran sulfate, the rate and intensity of hybridization 
is elevated approximately ten-fold by increasing the effective 
concentration of the probe in the hybridization solution 
(Amasino, 1986; Wahl et al., 1979}. The effect of dextran 
sulfate was tested on hybridization to intact human fibroblast 
cells. Two strips of glass fiber filter with triplicate 
samples were hybridized to the al(I) probe in solution with or 
without dextran sulfate. The signal obtained with cells 
hybridized in the presence of dextran sulfate was about 2-fold 
higher than that without it (Figure 16}. Furthermore, the 
background signal was higher in the absence of dextran 
sulfate. The increase in hybridization signal may be contrib-
uted by dextran sulfate's ability to protect the cellular 
m.RNAs. This fact is supported by a study done by Lawrence and 
Singer (1985} which showed that in the absence of dextran 
sulfate, the retention of the total cellular RNA was reduced 
by more than 50%. Consequently, all hybridizations were 
carried out in solution containing 10% dextran sulfate. 
Prehybridization 
Standard hybridization requires prehybridization of the 
filter in hybridization solution lacking probe to reduce 
background (Sambrook et al., 1989). The necessity of this 
step was tested for hybridization to RNA in intact cells. The 
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filters were prehybridized at 45°C in hybridization solution 
minus the probe. The probe was then added to the hybridiza-
tion solution and the filters incubated overnight. The 
results showed no difference in signal-to-noise ratio between 
prehybridized and non-prehybridized filters (Figure 17). 
Consequently, no prehybridization step was included in the 
protocol. 
HYBRIDIZATION SPECIFICITY 
As for all hybridization procedures, controls to prove 
the specificity of detection reactions have to be performed. 
Three different approaches were taken to insure that the cross 
hybridization to other collagen gene family members, other 
structurally similar genes, and other cellular components was 
kept to a minimum. 
Cross Hybridization Between Probes 
The first approach was to test the extent of cross 
hybridization of the probes used in this study to other 
collagen and structurally similar genes. A Gene Screen Plus 
filter containing all relevant clones was hybridized to each 
of the probes used in this study; al(I), a2(I), 6 actin, or 
28S rRNA (Figure 18A and B) . several hybridization stringen-
cies were tested until one was found that yielded the least 
cross hybridization signal (less than 10%) without reducing 
the hybridization to the target cDNA by more than two-fold. 
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These hybridization conditions were used in the quantitation 
experiments. The results of cross hybridization between the 
different probes are summarized in Figure 18C. The RNA probes 
allow for extreme sensitivity and as a result cross hybridiza-
tion of less than 1% was easily detectable. The al(I) probe 
cross hybridizes to al(III) and a2(I) cDNAs at about 3.5% 
each. It also cross hybridized to a2(V), B actin, and a 
tubulin for a total cross hybridization of 9.5%. Similarly 
a2(I) cross hybridized with al(I) only for a total of 8.5%. 
The B actin cross hybridized to other cDNAs for a total of 
less than 5%. The 28S rRNA nick translated probe did not 
cross hybridize to any of the other genes. 
Strand Specificity 
The second approach was designed to test the probes' 
faithfulness in hybridization only to the target mRNA and not 
to non-specific cell components. Fixed cells were loaded onto 
the poly-L-lysine-coated glass fiber filters and treated as 
described in Materials and Methods. The filters were then 
hybridized to either the sense or the anti-sense strand RNA 
probes. The probes were prepared by the in vitro transcrip-
tion of the plasmids with inserts cloned in opposite orienta-
tions as described earlier (see Materials and Methods and the 
Results sections on RNA synthesis). The best results were 
obtained with the al(I) collagen probe, 4z6771 (Figure 19A). 
The signal from the hybridization to the anti-sense strand was 
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15- to 25-fold higher than that obtained from the hybridiza-
tion to the sense strand. The low background hybridization 
with the sense strand is inherent to in situ hybridization in 
general since similar background hybridization is obtained by 
the hybridization of any sequence (e.g., pBR322 vector 
sequence) to intact cells (data not shown). Thus to a small 
extent, the RNA probe binds non-specifically to cellular 
components and/ or it may not be washed out of the cells 
completely. 
The strand specificity of a2(I) and B actin probes is 
not as good as the al(I) probe. The difference between the 
sense and the anti-sense strands is three- to four-fold in 
these cases (Figure 19A). The intensity of a2 (I) sense strand 
hybridization is higher than that obtained with the sense 
strand for al(I), but the signal with the anti-sense strand is 
lower than the al(I) counterpart. Therefore, the decrease in 
the difference between the two strands is partly due to the 
presence of fewer transcripts for a2(I) per cell in comparison 
to al(I) mRNA. There also may be a higher incidence of cross 
hybridization between the sense strand and other similar mRNAs 
and cellular component with the a2(I) and B actin probes as 
shown by the increase in the hybridization signal with that 
strand. 
Ribonuclease A Treatments 
The third approach was the treatment of cells with 
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ribonuclease A either prior to or after hybridization. These 
experiments were designed to test whether the probe was 
hybridizing only to its target RNA, and also to test the 
efficiency of removal of unhybridized probe out of the cells 
by washing. Fibroblast cells loaded onto the filters were 
treated with ribonuclease A prior to hybridization to degrade 
the cellular RNA. The filters were then hybridized to the 
al(I) RNA probe. As shown in Figure 19B the hybridization 
intensity of RNased cells is much lower than that for non-
treated cells. No significant difference is seen between 
cells treated with 5 or 10 ug/ml of RNase A indicating that 
cellular RNA was easily accessible and was degraded with the 
lesser concentration of the ribonuclease A. A comparison 
between untreated cells hybridized in the same bag with 
treated cells, and untreated cells hybridized in a separate 
bag show about 2-f old higher signal in the latter case, 
indicating that the RNase A may have still been slightly 
active and degraded some of either the RNA probe or the 
cellular RNA in the untreated cells. In any case, in the 
absence of cellular RNA, the hybridization signal is very 
weak, indicating that the probe is not binding non-
specifically to other cellular components. 
The treatment of cells with ribonuclease A after 
hybridization degrades all of the unhybridized RNA molecules 
(both probe and cellular RNA) and also the unpaired (ssRNA) 
regions of the RNA-RNA hybrid formed between the probe 
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molecules and the m.RNA to which it is hybridized. As can be 
seen in Figure 19C the untreated cells yield a signal that is 
30-60 fold higher than that for the treated cells. This 
experiment indicates that there are a large number of regions 
in the RNA-RNA hybrid that are unpaired and are susceptible to 
the degradative activity of the ribonuclease A. One possibil-
ity may be that there is more than one probe molecule bound 
per target m.RNA. In light of results from experiments on the 
probe saturation and probe size, this situation is likely to 
be occurring {see Conclusion). 
The final treatment and hybridization parameters for the 
optimum hybridization to the cellular mRNA are summarized in 
Figure 20. These conditions were used in the quantitation 
experiments below. 
Quantitation of the Relative Amounts of Collagen Type I mRNA 
in Normal and OI Fibroblasts 
After establishing all the parameters and conditions for 
the optimum hybridization to RNA in intact cells, the quant-
itation of the al{I), a2(I), B actin and 28S ribosomal RNA in 
various cells was done. The purpose of these experiments was 
to determine if the fibroblasts from two OI individuals differ 
significantly in the levels of Type I collagen mRNAs from that 
in the normal fibroblast cells. Two cell lines (GM02962 and 
GM0744) from individuals with the lethal form of osteogenesis 
imperfecta and one cell line (GM03348B) from a normal individ-
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ual were used. All efforts were made to ensure that the same 
degree of growth and confluency was reached by all cell lines. 
aowever, since or fibroblasts have a slower rate of growth 
than normal cells and also because there are differences in 
the cell size among the different cell lines, or cultures had 
to be grown for relatively longer periods of time. Further-
more, in order to eliminate any variation in the harvesting, 
fixing, and age of the fixed cells among different trials, 
every or cell line was harvested and fixed along with a batch 
of normal cells to which it was compared. The 285 rRNA was 
also used as an internal control to standardize any varia-
tions. 
After fixing of the cells, three data points each with 
increasing number of cells of both or and the corresponding 
control cells were treated under identical conditions as 
described in Materials and Methods. Figure 21 summarizes the 
results in terms of the slopes of the first order linear 
regressions. It is apparent that the steady state levels of 
al and a2 could not be compared within the same cell line 
since the ratio of the two mRNAs is not 2:1 even in the normal 
fibroblasts. This is not only because of the difference in 
the size of the two probes but more importantly due to the 
effect of the binding of more than one probe molecule per 
target mRNA (see Conclusion for explanation). Therefore, the 
results here are expressed as the ratio of collagen mRNA to 
the 28S RNA. The latter was an internal control that served 
as a measure of the total RNA in each cell line. 
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It has 
previously been shown to be a reliable control for such 
purposes (Leeuw et al., 1989). As can be seen the steady 
state levels of the total RNA in both of the OI cell lines are 
higher than in the normal fibroblast cells. It can also be 
seen that the increase in the total RNA is not correlated with 
a proportionately equal increase in the amount of al and a2 
collagen mRNAs in both cell lines (e.g., the ratio of either 
collagen mRNA to the rRNA in GM0744 OI cells is much lower 
than that in the normal cells). This may imply that there is 
a coordinate down regulation of both collagen genes. In cell 
line GM0744, the ratio of al(I) to a2(I) is the same as the 
ratio of the two mRNAs in the normal cell line, GM03348B, 
indicating that the relative ratio of the Type I collagen 
mRNAs is normal but that they are under-expressed in terms of 
their absolute amounts. In cell line GM02962 on the other 
hand, the ratio of the two mRNAs is lower than normal (1.55 
vs. 2.7, respectively) and only the al(I) gene seems to be 
under-expressed. The ratio of the a2(I) mRNA to the 285 rRNA 
is the same in both GM02962 and the normal cell line. 
The results of previous work done by de Wet and his 
colleagues (1983a, 1983b) on cell line GM0744 indicated that 
this cell line has the same ratio of al(I): a2(I) mRNA as 
that found in the normal control fibroblasts, GM03348B. The 
results presented here also show that the ratio of the two 
mRNAs in GM0774 is the same as that in the normal cell line, 
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GM03348B. However, the absolute amounts of the two mRNAs are 
iower than normal, which the earlier study could not show due 
to the lack of internal controls. Cell line GM02962, on the 
other hand, was shown in the earlier studies (de Wet et al., 
1983a; de Wet et al., 1983b) to contain three times as much 
al(I) as a2{I) mRNA. The results presented here, however, 
indicate that al{I) is under-expressed and thus the ratio of 
al(I) to a2(I) is less than the normal 2 to 1. The cause of 
this contradiction is not known. The collagen protein levels 
have been shown (de Wet et al., 1983a and b) to correlate with 
the levels of collagen mRNAs present in these cell lines. 
There is some disagreement as to whether the collagen 
mRNA levels vary between cells at different stages of growth. 
A number of studies have suggested that there is a significant 
difference in the levels of the Type I collagen mRNA in 
fibroblasts harvested at different stages of growth confluency 
(Tolstoshev et al., 1981). Others maintain that there is no 
appreciable variation (Voss and Bornstein, 1986). Preliminary 
results (data not shown) studying collagen mRNA levels in 
cells grown at different cell densities showed a very small 
amount of variation, certainly not sufficient to account for 
the differences in the mRNA levels seen between the normal and 
OI cells. Therefore, these differences reflect the inherent 
amounts of Type I collagen mRNA in these cell lines. Also, 
apparent variation in the amount of mRNAs due to differences 
in susceptibility of each cell line to proteinase K treatment 
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was ruled out experimentally. or cells were used in 
experiments similar to those on proteinase K digestion 
described above and the difference between OI and normal cells 
was consistent at a whole range of proteinase K digestion 
conditions (data not shown). 
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Figure 6. Size analysis of RNAs synthesized from pGEM4z 
plasmids. Aliquots of the different radioactive RNAs synthe-
sized by in vitro transcription were electrophoresed in a 1% 
denaturing agarose gel containing o. 66 M formaldehyde as 
detailed in Materials and Methods. The gel was dried and the 
autoradiogram prepared by direct exposure of the gel to the X-
ray film. Lane 1 is RNA transcribed from a positive control 
template of 1386 bp in length. Lanes 2 and 3 are the 1.5 kb 
anti-sense and sense RNAs for al (I) made from 4z6771 and 
4z6772, respectively. Lanes 4 and 5 are the 1.9 kb sense and 
anti-sense RNAs for B actin made from 4zA1 and 4zA2, respec-
tively. Lanes 6 and 7 are the 1.2 kb anti-sense and sense 
RNAs for a2 (I) made from 4z32s using SP6 or T7 promoter, 
respectively. The SP6 promoter is used for the transcription 
of all of the inserts except the sense transcripts of a2(I), 
lane 7, where the T7 promoter is used. The letter A points to 
a band that is smaller than the expected size of the B actin 
transcript. Letter B points to a minor band corresponding to 
the pGEM-4z vector sequence. 
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Figure 7. Effects of fixatives on cellular RNA hybridization. 
Filters with triplicates of 5000 cells per dot, of paraformal-
dehyde (PF) or glutaraldehyde (GA) fixed cells (GM03348B), 
were prepared as described in Materials and Methods. The 
filters were treated with 10 ug/ml of proteinase K at 37°C for 
the times indicated and hybridized with 40 ng/ml of al(I) RNA 
probe in 0.2 ml/cm2 of hybridization solution for 16-20 hours 
at 45°C. (A): A representative autoradiograph of these 
experiments. (B): Graphic representation of the results. The 
open and closed circles (O, •>are two independent experiments 
representing hybridization to glutaraldehyde fixed cells. The 
open and closed triangles (6 1 •) are two independent experi-
ments representing hybridization to paraformaldehyde fixed 
cells. Each point is the average of three replicates. The 
signal is presented as percent of maximum CPM obtained 
(include all trials for both fixatives). Each curve is the 
average of two independent experiments. 
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Figure 8. Effects of RNA and nick-translated probes on 
hybridization to cellular RNA. Two identical sets of filters 
with triplicates of 5000 cells per dot, of glutaraldehyde- or 
paraformaldehyde-fixed cells (GM03348B), were prepared as 
described in Materials and Methods. Both sets of filters were 
treated with 10 ug/ml of proteinase K for the amount of time 
(minutes) indicated on the left. Filters in set A were 
hybridized with 40 ng/ml of al(I) RNA probe. Filters in set 
B were hybridized with 40 ng/ml of nick translated al (I) 
probe. The hybridization was carried out in o. 2 ml/cm2 of 
solution for 16-20 hours at 45°C. The filters were washed and 
exposed to X-ray film for the same amount of time. 
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Figure 9. Effects of proteinase K treatment on hybridization. 
(A}: Proteinase K concentration. Triplicates of 5000 glutar-
aldehyde-fixed cells (GM03348B) per dot were loaded onto poly-
L-lysine-coated glass fiber filters as described in Materials 
and Methods. The filters were incubated with increasing 
amounts of proteinase K (0-50 ug/ml) for 40 minutes at 37°C. 
The filters were then hybridized to 40 ng/ml of al(I) RNA 
probe in 0.2 ml/cm2 of solution for 16-20 hour at 45°C. The 
data are presented as percent of maximum CPM obtained in each 
experiment and the curve drawn is the average of the two 
independent experiments. The slopes of the two experiments, 
using data points from 10 to 50 ug/ml of proteinase K, are 
negative but statistically not different from each other 
(Analysis of co-variance; P=0.923; Systat, 1989, Systat, 
Inc.). However, the analysis of co-variance test shows that 
the slope of the average of the two experiments (-0.311) is 
significantly different from zero (P=0.002). (B): Digestion 
Time. Filters prepared in the same manner as in A were 
treated with constant amount of proteinase K (10 ug/ml) but 
for varying periods of time (0-70 minutes). The amount of 
probe, hybridization solution and hybridization conditions are 
the same as above. The results are presented as percent of 
maximum CPM and the plot is the average of two experiments. 
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Figure 10. Effects of hybridization volume on hybridization. 
The results of two identical experiments {solid and hatched 
box) each with four different hybridization volumes are shown. 
Each bar represents an average of triplicate samples of 5000 
cells per dot (Cell line GM03348B) prepared as described in 
Materials and Methods. The filters were treated with 10 ug/ml 
of proteinase K for 40 minutes at 37°C. The filters were then 
hybridized with 40 ng/ml of al (I) collagen RNA probe in 
varying amount of hybridization solution (0.08, 0.10, 0.20, or 
o.30 ml/cm2) for 16-20 hours at 45°C. The data are presented 
as percent of maximum CPM obtained in each experiment. 
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Figure 11. Cell number linearity and retention. (A): Trip-
licates of 5 to 30 thousand cells {GM03348B) spotted onto 
poly-L-lysine-coated glass fiber filters were treated and 
hybridized to the al(!) collagen RNA probe as described in 
Materials and Methods. The results are presented as percent 
of maximum CPM obtained in each experiment. The curve drawn 
is the second order regression for the two independent 
experiments {O, •>· (B): A more detailed study of linearity 
within the usable range, 1-14 thousand cells. The conditions 
were identical to the above experiments and the curve drawn is 
the first order regression for the two experiments (A, &). 
(C): Retention of cells onto the glass fiber filters. Human 
fibroblasts (GM03348B) labeled with 3H-thymidine were used in 
an experiment identical to that in A except the probe was not 
included in the hybridization. Again a second order regres-
sion line was drawn of CPM vs. the number of cells. The error 
bars are the standard deviations for each point. 
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Figure 12. Time dependence of in situ hybridization and cell 
retention. (A): Hybridization time. Filters with triplicates 
of 5000 cells per dot of glutaraldehyde-f ixed cells (GM03348B) 
were prepared and hybridized to the al(I) RNA probe in 0.2 
ml/cm of hybridization solution at 45°C for periods of times 
indicated on the X-axis. Because the theoretical form of the 
kinetics is not known, the connection of the points serves to 
facilitate visualization of the data. (B): Cell retention. 
cells labelled with 3H-thymidine were loaded onto the filters, 
treated and hybridized as in A except the probe was excluded 
from the hybridization solution. First order regression was 
drawn to aid in visualization. The error bars are the 
standard deviations for each point. The correlation 
coefficient (R) value =4.0872X10· 1 • Therefore, one point is 
not significantly different from another, and the line is 
straight. 
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Figure 13. Effects of probe size on hybridization. (A) : 
Triplicates of 5000 normal fibroblast cells (GM03348B) per dot 
were loaded onto filters and treated as described in Materials 
and Methods. The filters were hybridized to al(I) RNA probes 
of different sizes and amounts (i.e., 40 ng/ml of each probe 
were used when equal amounts of the two probes were compared, 
40 ng/ml of the larger probe and 18 ng/ml of the smaller probe 
were used when equal numbers of transcripts were compared). 
The hybridization was carried out in 0.2 ml/cm2 of solution 
for 16-20 hours at 45°C. The washing temperatures employed 
are indicated on top. All filters were exposed to X-ray film 
for the same amount of time. (B): Summary of the results of 
the experiment. The results are expressed as the ratio of 
counts per minute of the larger (4z6771/Xba I, 1.5 kb) probe 
to that for the smaller (4z6771/Xho I, o.7 kb) probe. 
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Figure 14. Probe saturation. Three separate experiments (O, 
e, a) each with some different data points are superimposed on 
each other. Each data point is the average of three samples 
of 5000 glutaraldehyde-f ixed cells (GM03348B) per dot hybrid-
ized to the al(I) RNA probe at the concentrations indicated on 
the x-axis. The hybridization was carried out in 0.2 ml/cm2 
of hybridization solution at 45°C for 16-20 hours. The 
results are expressed as percent of maximum counts per minute 
obtained in each experiment. 
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Figure 15. Cell storage: Fibroblasts from cell line GM03348B 
were harvested and fixed with 1% glutaraldehyde on different 
dates as outlined in Materials and Methods. The cells were 
stored for up to four months in 70% ethanol at -20°C before 
hybridization. Filters with triplicates of each sample (5000 
cells per dot) were prepared and hybridized to 40 ng/ml of 
the al(I) RNA probe at 45°C for 16-20 hours in a volume of 0.2 
ml/cm2 • The filters were washed and the counts per minute of 
hybridization are presented. The error bars represent the 
standard deviations between the triplicates in each point. 
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Figure 16. Dextran sulfate. Normal human fibroblast cells 
(GM03348B) immobilized onto fiber filter at 5000 cells per 
dot, were hybridized to 40 ng/ml of al(I) RNA transcripts in 
0.2 ml/cm2 of hybridization solution with (A) or without (B) 
10% dextran sulfate. The hybridization was carried out at 
45°C for 16-20 hours. After washing the filters they were 
exposed to X-ray film for the same amount of time. 
93 
A 13730 ± 816 
B 14850 ± 724 
Figure 17. Effects of prehybridization. Samples of 5000 cells 
(GM03348B) per dot were loaded onto poly-L-lysine coated glass 
fiber filters and treated as described in Materials and 
Methods. Strip A was prehybridized in hybridization solution 
without the probe for 4 hours at 45°C. Forty ng/ml of al(I) 
RNA probe was added to filter A and at the same time filter B 
was incubated with hybridization solution containing the 
probe. The filters were hybridized in 0.2 ml/cm2 of solution 
for 16-20 hours at 45°C. The filters were then washed and 
exposed to X-ray film for the same amount of time. The actual 
counts per minute and the standard deviation are presented on 
the left. 
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Figure 17. Effects of prehybridization. Samples of 5000 cells 
(GM03348B) per dot were loaded onto poly-L-lysine coated glass 
fiber filters and treated as described in Materials and 
Methods. Strip A was prehybridized in hybridization solution 
without the probe for 4 hours at 45°C. Forty ng/ml of al(I) 
RNA probe was added to filter A and at the same time filter B 
was incubated with hybridization solution containing the 
probe. The filters were hybridized in 0.2 ml/cm2 of solution 
for 16-20 hours at 45°C. The filters were then washed and 
exposed to X-ray film for the same amount of time. The actual 
counts per minute and the standard deviation are presented on 
the left. · 
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Figure 18. Cross hybridization. (A): A representative agarose 
gel containing Hf32/Eco RI (a2(I)], lane 1, 4z6771/Eco RI (3' 
portion of al(I)], lane 2, 4z4041/Eco RI (5' portion of 
al(I)], lane 3, pTl/Pst I (a tubulin), lane 4, pAl/Pst I (B 
actin), lane s, pLh14/Eco RI (al(III)], lane 6, Hf511/Eco 
RI[a2(V)], lane 7, Ok25/Eco RI (a2(V)], lane 8, pXlr-11/Eco RI 
(28S rRNA), lane 9, pXlr-12/Eco RI (18S rRNA), lane 10. The 
DNA was transferred to Gene Screen Plus membrane. A membrane 
was hybridized to either al(I), a2(I), B actin or 28S rRNA 
probes. (B): A representative autoradiograph of a membrane 
hybridized with the al(I) probe. The hybridized bands on the 
Gene Screen Plus were punched out and counted in a scintilla-
tion counter. (C): Summary of cross hybridization. The 
hybridization of the probe to its own cDNA are considered to 
be 100% and the rest of the results are presented as the ratio 
of cross hybridization to self hybridization. 
95 
co 
-..,, ,,,,, I 
N , ' . • 
I 
I ~ 
0 
I , 
rot 
11 en 
' 
co •, """' I ID 
"" I I 
oi::r .. 1 · I 
I 
,. .. 
. 
' 
. 
C"') 
. 
~ 
,. . N 
' 
,. c:c rot 
' 
c 
Probes al (I) a2(I) al(III) a2(V) B act in a tubulin 18S 28S Total 
al (I) 100% 3.6% 3.2% 1.5% 0.5% 0.7% 0% 0% 9.5% 
a2(I} 8.5% 100% 0% 0% 0% 0% 0% 0% 8.5% 
B actin <1% <1% <1% <1% 100% <1% 0% 0% <3% 
28S 0% 0% 0% 0% 0% 0% 0% 100% 0% 
97 
Figure 19. Hybridization specificity. {A): Strand specifici-
ty. Triplicates of 5000 cells (GM03348B) per dot were loaded 
onto the glass fiber filters and treated as described previ-
ously. One strip was hybridized to 40 ng/ml of either the 
sense or the anti-sense strand of al(I), a2{I) or B actin RNA 
probes. The dots were later punched out and counted in the 
scintillation counter. The results from representative 
experiments are presented as counts per minute plus the 
standard deviation for each probe. {B): Ribonuclease A 
treatment prior to hybridization. Cells loaded onto the 
filters were treated as described in text. Filters A and D 
were treated with O ug/ml RNase A for 30 minutes at 37°C. 
Filter B was treated with 5 ug/ml and filter C with 10 ug/ml 
RNase A at 37°C for the same length of time as above. Filters 
B, C, and D were hybridized in one bag. Filter A was 
hybridized in a separate bag. (C): Ribonuclease A treatment 
after hybridization. Two strips with triplicates of 5000 
cells per dot were treated and hybridized with al (I) RNA 
probe. Only one of the strips (B) was treated with 5 ug/ml of 
RNase A for 30 minutes at 37°C. In the autoradiograph shown 
filter B was exposed for four times as long as filter A. The 
actual counts and the standard deviation for both B and C are 
presented on the right. 
A 
Sense Strand Anti-Sense Strand Anti-sense/Sense 
al(I) 150 ± 14 2841 ± 39 18.9 
a2(I) 771 ± 153 1983 ± 483 2.6 
B actin 3202 ± 467 9383 ± 1480 2.9 
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Load 5000 cell onto poly-L-lysine coated glass fiber 
filter under 40 mm Hqlvacuwn and let air dry 
Incubate with 10 ug/ml of proteinase K at 37°C for 
40 minutes,·followed by triethanol amine and acetic 
anhydride treatmjnts, let air.dry 
Hybridize with 4·o ng/ml of RNA probe in 0.2 111/cm.2 of 
hybridization solution containing lOt dextran sulfate 
for 16-20 hours at 45°C · 
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Wash with o.os X SSC at 65°C, expose to X-ray film, 
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Figure 20. Procedural flow chart based on the optimal treat-
ment and hybridization parameters. 
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Slopes 
GM0744 GM03348B GM02962 GM03348B 
a1(I) 1.8517 1. 3708 2.3701 0.9885 
a2(I) 0.5760 0.4355 1.5336 0.3675 
rRNA 1.1825 0.2250 1.1550 0.2680 
Ratios of Slopes 
GM0744 GM03348B GM02962 GM03348B 
a1/a2 3.2 3.1 1.55 2.7 
~ 
al/rRNA 1. 7 6.09 2.05 3.7 
a2/rRNA 0.5 1.94 1.33 1.37 
Figure 21. Quan ti tation of the relative amounts of Type I 
collagen and the ribosomal RNA in OI and normal human f ibro-
blasts. Cell lines indicated on the top were fixed with 1% 
glutaraldehyde, triplicates of 2,4 and 8 thousand cells were 
loaded onto poly-L-lysine-coated glass fiber filters, and 
treated as described in Materials and Methods. Each OI cell 
line (GM0744 and GM02962) was accompanied by normal fibro-
blasts (GM03348B) which served as a control and a base for 
comparison. (A): The results are presented as the slopes 
(counts per cell) of ... the first order regression line connect-
ing data points of each cell line for each probe. (B): The 
amount of each collagen species is also presented as the ratio 
of the collagen slope to the 28S rRNA slope in addition to the 
ratio of the slopes of th~ al (I) to a2 (I) • The coefficient of 
variation (V) for two independent trials with cell lines 
GM03348B, GM02962, and GM0744 are 19%, 35% and 0.16%,· respec-
tively. 
CONCLUSION 
The goal in this study was to develop a quick method for 
the quantitative determination of the steady state levels of 
Type I collagen mRNA in fibroblast cells from normal and OI 
affected individuals. In situ hybridization was chosen 
because of the advantages it offers: the ease with which this 
technique is performed, the capability of analyzing a large 
number of different samples at the same time, and the elimi-
nating of the need for the isolation and handling of the 
sensitive RNA. 
Although in situ hybridization techniques have been 
known for a long time and a great deal of information is 
available, not much was known about hybridization to human 
fibroblast cells grown in cell culture. consequently, the 
combination of variables affecting hybridization to messenger 
RNA in situ had to be worked out. In testing each parameter, 
maximal hybridization signal, minimal background, and maximal 
hybridization specificity served as the basic criteria. 
The choice of fixative is important so as to povide for 
the maximum RNA retention and thus the highest hybridization 
signal. In agreement with the conclusions of other research-
ers (Lawrence and Singer, 1985; Yu and Gorovsky, 1987; Angerer 
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and Angerer, 1981) 1% glutaraldehyde crosslinks the cellular 
matrix extensively and thus ensures maximum RNA retention and 
a high hybridization signal. However, due to this property of 
glutaraldehyde, extended digestion with proteinase K is 
required to achieve maximum penetration of the probe into the 
cell. Paraformaldehyde, on the other hand, fixes the cells in 
a more open configuration and thus renders the cellular RNA 
more accessible to the probe without the need for extensive 
proteolytic treatment (Lawrence and Singer, 1985), and thus 
may be more suitable for situations where the preservation of 
cellular morphology is essential. One disadvantage to the use 
of paraformaldehyde for fixation is that it does not retain 
and/or protect the RNA as well as glutaraldehyde and conse-
quently does not provide for the maximum signal. Also as a 
result paraformaldehyde-fixed cells can not be stored as long 
as glutaraldehyde-fixed cells. Once glutaraldehyde had been 
chosen as the fixative the other parameters (i.e., proteinase 
K treatment, hybridization volume and time, prehybridization, 
and dextran sulfate etc ••• ) were tested and optimized. Figure 
21 shows a flow chart of the final procedure with all of the 
parameters listed. 
The type of probe employed 
variable that had to be decided upon. 
is another independent 
Although nick translat-
ed probe could be used for in situ hybridization, single 
stranded anti-sense RNA probes are clearly superior for 
several reasons. Aside from their high specific activity and 
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the constant probe size, RNA-RNA hybrids formed by the pairing 
of the probe to its target mRNA have a higher thermal stabili-
ty than RNA-DNA or DNA-DNA hybrids (Casey and Davidson, 1976). 
This stability contributes to the increased probe specificity 
and reproducibility of the hybridization reaction. RNA probes 
are strand-specific and do not contain vector sequences. This 
prevents non-specific hybridization or competitive hybridiza-
tion between the complementary strands as occurs with nick-
translated probes. The latter fact contributes to the much 
higher signals obtained with RNA probes than with nick-
translated DNA probes. Also, the ability to use ribonucleases 
to digest away unhybridized and unmatched probe provides for 
a greater specificity and a very low background which in turn 
leads to an even higher sensitivity (Zinn et al., 1983). 
An unexpected factor that proved to be very critical in 
the interpretation of quantitation experiments is the poten-
tial for the amplification of the signals by RNA probe 
hyperpolymer formation on target mRNAs. Three pieces of 
evidence suggest that such events are occurring here. First, 
experiments comparing probe sizes (Figure 13) showed a 7-fold 
greater intensity of hybridization with a 1.5 kb probe than 
one of o. 7 kb. This was not due to differences in the 
specific activity of the probes or to greater stability of the 
RNA-RNA hybrids with the longer probe. Second, probe satura-
tion experiments (Figure 14) showed that there are 60000 
copies of al(I) mRNA per fibroblast cells. As mentioned 
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earlier this number is several times higher than usual for a 
high abundance transcript. Third, the treatment of hybridized 
cells with RNase A (Figure 19C) caused a drop in the hybrid-
ization intensity by some 30- to 60-fold, indicating the 
presence of a great amount of partially hybridized single 
stranded probe. To explain these events, the following 
hypothesis is put forth: RNA localized inside a fixed cell is 
most likely surrounded and/or wrapped around complex molecules 
such as proteins of the translation machinery. As a result 
certain regions of the target mRNA are free to hybridize to 
the probe and others are not. Furthermore, the free regions 
of the mRNA are separated by large molecules such as ribo-
somes. This would make every free portion of the mRNA a 
target for a different probe molecule and results in the 
binding of more than one molecule of the probe per each Type 
I collagen mRNA. The number of probe molecules bound to the 
target RNA is dependent on its size (i.e., larger probes bind 
at a higher number than smaller probes). However, as can be 
see from the probe size experiments, doubling the size of the 
probe causes a seven fold increase in hybridization signal, 
indicating that the number of molecules binding per target 
mRNA is not linear. The reason for this is not clear at 
present. Consequently, results obtained by the use of probes 
with different sizes can not be compared directly. 
Therefore, probe size can play a major role in the 
quanti tat ion of mRNA in intact cells. In cases where absolute 
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numbers of transcript are sought, smaller sized probes (Yu and 
Gorovsky, 1987; Lawrence and Singer, 1985) must be used or 
RNase A treatment must be a regular part of the washing 
procedure to eliminate the effects of hyperpolymer formation 
(Cox et al., 1984). However, when maximum sensitivity is 
required for detection of a rare transcript, or when the 
relative ratio of a particular mRNA species between different 
cell lines is desired, then larger probes may be used. 
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